Fibrosis and cirrhosis of liver

K11_FIBROCHIRLIV

cirrhosis of liver: A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholism, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K74 Hospital discharge: ICD-9 — 571[5-6] Hospital discharge: ICD-8 — 5719 Cause of death: ICD-10 — K74 Cause of death: ICD-9 — 571[5-6] Cause of death: ICD-8 — 5719 2 out of 7 registries used, show all original rules.	3507
4. Check minimum number of events None	3507
5. Include endpoints None	3507
6. Filter based on genotype QC (FinnGen only)	3168

Control definitions (FinnGen only)

Control exclude: K11_LIVER

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: K70-K77
Name in latin: Fibrosis et cirrhosis hepatis

NAME	K11_FIBROCHIRLIV
CONTROL_EXCLUDE	K11_LIVER
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K74
HD_ICD_9	571[5-6]
HD_ICD_8	5719
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K74
COD_ICD_9	571[5-6]
COD_ICD_8	5719
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Fibrosis and cirrhosis of liver based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	23725	11371	11894
Only index persons	16446	8181	8265
Unadjusted period prevalence (%)
Whole population	0.33	0.33	0.33
Only index persons	0.31	0.30	0.32
Median age at first event (years)
Whole population	63.88	64.27	63.53
Only index persons	63.60	63.15	64.04

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3168	1579	1589
Unadjusted period prevalence (%)	0.64	0.56	0.73
Median age at first event (years)	64.23	61.67	66.76

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3264: Matched controls
32640

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

24.6

311.6

223

D97

ICPC

Liver disease NOS

50.8

308.4

178

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

5.8

307.7

922

2060

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

45.4

307.7

747

212

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

6.3

307.7

1157

2613

K76.9

ICD-10 Finland

Liver disease, unspecified

197.0

307.7

336

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

102.0

307.7

403

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

30.8

307.7

458

172

K74.3

ICD-10 Finland

Primary biliary cirrhosis

11508.4

307.7

865

Z94.4

ICD-10 Finland

Liver transplant status

193.6

307.7

217

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

550.2

307.7

659

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

11219.5

307.7

2202

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

39.7

307.7

444

129

A05AA02

ATC

ursodeoxycholic acid; oral

149.4

307.7

916

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

7553.0

307.7

626

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

6.9

307.7

2117

6911

C03CA01

ATC

furosemide; systemic

4.5

307.7

1876

7483

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

64.7

307.7

316

R18

ICD-10 Finland

Ascites

44.6

307.7

696

197

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

10.8

307.7

1183

1637

A07AA11

ATC

rifaximin; oral

207.3

307.7

195

C03DA01

ATC

spironolactone; oral

9.6

307.7

1439

2470

A06AD11

ATC

lactulose; oral

4.4

305.4

1022

3083

K74.0

ICD-10 Finland

Hepatic fibrosis

+∞

299.7

283

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

49.9

271.1

157

C07AG02

ATC

carvedilol; oral

5.9

268.5

541

1064

JCA22

NOMESCO Finland

Endoscopic ligature of oesophageal varices

401.6

263.0

261

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

42.5

263.0

158

127

Kela drug reimbursment

Transplant complication

14.8

258.9

236

171

K83.0

ICD-10 Finland

Cholangitis

13.4

231.8

223

177

A10AE04

ATC

insulin glargine; parenteral

4.4

231.4

688

1865

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

9.3

225.0

282

329

103

Kela drug reimbursment

Diabetes, insulin-treated

3.2

221.3

1446

6531

K92.0

ICD-10 Finland

Haematemesis

9.8

216.2

258

282

L04AA06

ATC

mycophenolic acid; systemic

11.0

212.9

234

228

I85.0

ICD-10 Finland

Oesophageal varices with bleeding

443.5

211.0

209

L04AD02

ATC

tacrolimus; systemic

18.7

208.3

167

B18.2

ICD-10 Finland

Chronic viral hepatitis C

20.9

199.9

152

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

3.1

199.4

1322

5947

D64.9

ICD-10 Finland

Anaemia, unspecified

3.8

196.4

732

2314

JJC00

NOMESCO Finland

Allogenic transplantation of liver

1007.0

195.9

190

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

2027.8

188.3

181

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

9.5

187.4

228

255

A10AB05

ATC

insulin aspart; parenteral

4.4

185.7

528

1370

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

10.5

178.9

202

204

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.9

177.1

1277

5938

K72.9

ICD-10 Finland

Hepatic failure, unspecified

306.1

171.6

173

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

9.2

166.4

207

238

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

+∞

163.9

156

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

11.1

163.5

177

168

L04AX01

ATC

azathioprine; systemic

5.8

158.3

309

581

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.9

154.5

520

1516

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.4

152.7

677

2363

A07EA06

ATC

budesonide; oral, local oral

6.1

152.6

278

489

T90

ICPC

Diabetes non-insulin dependent

2.7

149.6

1239

6080

A10BH01

ATC

sitagliptin; oral

3.5

148.8

603

1987

JN3AD

NOMESCO Finland

Abdominal CT examination

3.1

148.0

749

2825

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

50.7

145.6

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

4.2

145.3

425

1118

K70.0

ICD-10 Finland

Alcoholic fatty liver

62.3

142.4

A10BA02

ATC

metformin; oral

2.6

142.3

1351

7046

K92.1

ICD-10 Finland

Melaena

4.4

141.9

386

960

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

481.4

140.4

139

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

5.8

135.8

262

486

K73.80

ICD-10 Finland

Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)

36.5

131.4

K72.1

ICD-10 Finland

Chronic hepatic failure

+∞

130.1

124

UJF32

NOMESCO Finland

Coloscopy

2.5

127.8

1211

6242

K74.5

ICD-10 Finland

Biliary cirrhosis, unspecified

+∞

126.9

121

N17.9

ICD-10 Finland

Acute renal failure, unspecified

4.6

123.4

309

718

L04AD01

ATC

ciclosporin; systemic

8.0

121.6

168

219

K70.4

ICD-10 Finland

Alcoholic hepatic failure

1212.1

120.6

117

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.6

117.7

859

3888

TK800

NOMESCO Finland

Hemodialysis

7.0

117.6

183

273

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

593.9

116.8

115

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

8.0

116.5

161

210

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.3

115.1

1980

13033

I81

ICD-10 Finland

Portal vein thrombosis

24.4

113.9

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

5.9

113.8

211

376

C07AA05

ATC

propranolol; systemic

2.6

112.5

842

3848

G93.4

ICD-10 Finland

Encephalopathy, unspecified

58.4

112.1

K76.7

ICD-10 Finland

Hepatorenal syndrome

+∞

112.1

107

A10AC01

ATC

insulin (human); parenteral

3.6

112.1

407

1237

N02AX02

ATC

tramadol; systemic, rectal

2.2

107.3

1728

10952

R17

ICD-10 Finland

Hyperbilirubinaemia, with or without jaundice, not elsewhere classified

8.6

107.0

139

168

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

105.7

993

5022

198

Kela drug reimbursment

Sorafenib

35.4

104.9

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.8

102.1

340

973

A10AE05

ATC

insulin detemir; parenteral

4.0

99.7

308

836

I50.9

ICD-10 Finland

Heart failure, unspecified

2.6

99.6

694

3043

K72.0

ICD-10 Finland

Acute and subacute hepatic failure

+∞

99.5

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.4

98.1

879

4331

UJF30

NOMESCO Finland

Ileoscopy through colon

2.9

97.5

535

2073

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.6

95.3

336

998

K75.4

ICD-10 Finland

Autoimmune hepatitis

+∞

95.3

R94.5

ICD-10 Finland

Abnormal results of liver function studies

9.3

94.4

115

128

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.5

94.1

354

1097

JJA20

NOMESCO Finland

Open biopsy of liver

25.5

92.9

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.1

92.9

1387

8390

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

3.3

90.8

374

1226

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

6.1

90.2

161

276

WW500

NOMESCO Finland

Blood transfusion

4.2

89.6

256

655

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.3

88.4

237

578

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

7.2

87.9

132

189

K70.1

ICD-10 Finland

Alcoholic hepatitis

444.4

87.5

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

4.6

86.8

218

505

A46

ICD-10 Finland

Erysipelas

2.5

86.4

696

3247

A10BB12

ATC

glimepiride; oral

3.2

86.2

372

1253

C22.9

ICD-10 Finland

Malignant neoplasm: Liver, unspecified

20.7

85.6

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.4

84.6

324

1013

E66.00

ICD-10 Finland

Metabolic syndrome

3.5

83.0

309

949

TJA10

NOMESCO Finland

Laparocentesis

23.1

81.3

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.6

81.1

551

2367

160

Kela drug reimbursment

exenatide

5.7

80.3

153

279

A41.9

ICD-10 Finland

Sepsis, unspecified

4.2

79.9

225

569

K29.6

ICD-10 Finland

Other gastritis

7.7

79.5

112

149

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

9.9

78.0

JJA21

NOMESCO Finland

Laparoscopic biopsy of liver

35.5

77.8

JN4AD

NOMESCO Finland

Body CT examination

2.5

77.6

580

2603

Z51.5

ICD-10 Finland

Palliative care

2.7

77.2

469

1903

A02BC02

ATC

pantoprazole; systemic

2.2

76.9

2459

19111

8000/3-C22.0

ICD-O-3

Neoplasm, malignant of liver

161.9

75.4

C10AC01

ATC

colestyramine; oral

4.9

75.0

168

354

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.3

74.7

725

3645

JJ5AT, ,

NOMESCO Finland

370.5

73.0

K29.7

ICD-10 Finland

Gastritis, unspecified

4.0

72.7

215

563

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.5

72.4

511

2227

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.7

71.4

442

1807

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

7.5

71.3

103

141

TPH07

NOMESCO Finland

Cathetrisation of artery

2.4

69.2

530

2397

SPAT1262

SPAT

Handing over of treatment supplies

2.2

68.8

731

3799

I50.0

ICD-10 Finland

Congestive heart failure

2.8

68.4

369

1403

J01MA02

ATC

ciprofloxacin; systemic

1.9

66.4

1449

9686

E87.5

ICD-10 Finland

Hyperkalaemia

5.2

64.9

137

274

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

134.7

62.1

UJK02

NOMESCO Finland

ERCP

4.3

61.8

165

400

ZX120

NOMESCO Finland

Intravenous

2.5

61.5

424

1820

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

4.8

60.9

139

297

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

23.5

60.9

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.8

60.7

327

1240

WX892

NOMESCO Finland

Monitored bed care

2.7

60.4

362

1451

XW000

NOMESCO Finland

Bone marrow biopsy

3.3

60.3

237

750

R50.9

ICD-10 Finland

Fever, unspecified

2.2

60.1

606

3066

K76.6

ICD-10 Finland

Portal hypertension

+∞

59.6

N17.8

ICD-10 Finland

Other acute renal failure

6.3

58.7

160

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.5

57.9

210

631

A10BH05

ATC

linagliptin; oral

3.0

56.0

267

946

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.3

55.8

464

2163

205

Kela drug reimbursment

Chronic hypertension

1.9

55.4

1046

6584

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.2

55.3

516

2524

ZXE40

NOMESCO Finland

More than seven and less than nine hours

4.6

55.0

134

302

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.0

54.9

755

4276

R4110

NOMESCO Finland

Physiotherapy

1.9

54.7

1039

6547

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

4.1

54.6

154

389

A10BX07

ATC

[U] liraglutide

6.1

54.5

162

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

53.0

1208

8031

A10BG03

ATC

pioglitazone; oral

4.1

52.5

149

378

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

3.1

52.0

230

780

177

Kela drug reimbursment

Insulin glargine 300 U / ml

4.9

51.3

115

242

M04AA01

ATC

allopurinol; systemic

2.1

51.2

560

2911

N02AA05

ATC

oxycodone; systemic

1.9

50.7

753

4365

F10.25

ICD-10 Finland

Alcohol dependence continuous use

5.5

50.4

182

A10BJ06

ATC

semaglutide; parenteral

2.9

50.3

257

945

EBA15

NOMESCO Finland

Extraction of multiple teeth

3.2

50.2

205

663

H02AB06

ATC

prednisolone; systemic

1.7

50.2

1654

12160

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.6

49.8

311

1268

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

4.9

49.5

110

230

5716A

ICD-9 Finland

Chronic liver disease and cirrhosis, Biliary cirrhosis[CIRRHOSIS BILIARIS PRIMARIA]

+∞

49.1

J01FF01

ATC

clindamycin; systemic

1.8

47.8

964

6140

P15

ICPC

Chronic alcohol abuse

4.0

47.8

141

368

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.6

47.6

164

476

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

10.8

47.1

A10BJ02

ATC

liraglutide; parenteral

3.7

47.0

152

423

K76.89

ICD-10 Finland

Other specified diseases of liver

464.3

46.4

S97

ICPC

Chronic ulcer skin

2.6

46.2

296

1221

K51.5

ICD-10 Finland

Left sided colitis

4.0

46.2

133

341

WX002

NOMESCO Finland

Sedation and analgesia

1.9

46.1

727

4281

162

Kela drug reimbursment

liraglutide

5.8

46.0

147

JN4CD

NOMESCO Finland

Very extensive body CT

3.2

45.6

188

611

J01MA12

ATC

levofloxacin; systemic

1.9

45.4

704

4120

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

45.3

601

3337

A10BX04

ATC

[U] exenatide

6.2

44.8

127

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

44.7

608

3404

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.9

44.7

216

770

R04.0

ICD-10 Finland

Epistaxis

2.4

44.6

340

1518

N19

ICD-10 Finland

Unspecified kidney failure

3.1

44.3

192

643

UJF92

NOMESCO Finland

Capsular endoscopy

4.3

43.7

113

267

K65.0

ICD-10 Finland

Acute peritonitis

6.1

43.6

127

R60.0

ICD-10 Finland

Localized oedema

2.0

43.6

512

2720

Z2446

NOMESCO Finland

Social worker

2.7

43.5

255

1006

R06.0

ICD-10 Finland

Dyspnoea

1.7

43.3

999

6582

E66.01

ICD-10 Finland

Obesity due to excess calories

2.4

42.8

331

1487

A10BK03

ATC

empagliflozin; oral

2.1

42.0

445

2273

K29.3

ICD-10 Finland

Chronic superficial gastritis

3.3

41.8

165

522

JDA52

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in stomach or pylorus

15.0

41.7

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

41.5

900

5813

K55.8

ICD-10 Finland

Other vascular disorders of intestine

10.4

41.4

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.7

41.3

132

364

WX872

NOMESCO Finland

Intensive care

2.7

41.2

238

931

UJD02

NOMESCO Finland

Gastroscopy

2.8

41.1

218

816

WVA20

NOMESCO Finland

Medicine administration

3.5

41.0

146

433

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.4

40.9

154

473

I86.4

ICD-10 Finland

Gastric varices

212.7

40.9

A41.8

ICD-10 Finland

Other specified sepsis

4.2

40.8

112

277

E66.8

ICD-10 Finland

Other obesity

2.8

40.8

210

774

R93.2

ICD-10 Finland

Abnormal findings on diagnostic imaging of liver and biliary tract

7.1

40.7

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.0

40.6

514

2800

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.9

40.0

119

312

Z2221

NOMESCO Finland

Medical doctor

1.7

39.8

900

5871

K74.2

ICD-10 Finland

Hepatic fibrosis with hepatic sclerosis

+∞

39.7

ZXD05

NOMESCO Finland

Urgent procedure

1.7

39.4

975

6516

Z3231

NOMESCO Finland

Registered nurse

1.7

39.4

936

6187

A28

ICPC

Limited function/disability NOS

1.8

39.3

690

4179

PC2DT

NOMESCO Finland

Embolisation of lesion of liver

74.5

39.0

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

38.8

893

5847

H02AB04

ATC

methylprednisolone; systemic

2.0

38.5

517

2869

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

38.4

455

2418

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.1

37.9

163

543

F10.24

ICD-10 Finland

Alcohol depence active use

5.1

37.9

160

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

6.0

37.6

111

57199

ICD-8 Finland

Cirrhosis of liver, Unspecified

+∞

37.6

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.0

36.9

169

584

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.4

36.8

263

1139

A10BD07

ATC

metformin and sitagliptin; systemic

2.7

36.6

199

754

A10BK01

ATC

dapagliflozin; oral

2.2

36.6

333

1599

JCA32

NOMESCO Finland

Endoscopic injection in oesophagus

54.4

36.4

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

3.4

36.3

135

412

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.7

36.2

938

6321

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.9

36.1

175

624

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.4

36.1

272

1206

E83.1

ICD-10 Finland

Disorders of iron metabolism

9.7

35.9

C07AB07

ATC

bisoprolol; oral

1.6

35.8

1715

13411

K83.1

ICD-10 Finland

Obstruction of bile duct

4.6

35.7

188

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.9

35.5

172

613

K70.2

ICD-10 Finland

Alcoholic fibrosis and sclerosis of liver

+∞

35.5

E66.9

ICD-10 Finland

Obesity, unspecified

3.1

35.3

149

491

M34.1

ICD-10 Finland

CR(E)ST syndrome

9.6

35.1

F10.20

ICD-10 Finland

Alcohol dependence currently independent

4.3

35.0

212

ZX108

NOMESCO Finland

Inhalation

6.5

35.0

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

34.9

569

3354

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.3

34.6

131

404

57309

ICD-8 Finland

Other diseases of liver, Unspecified

+∞

34.4

B82

ICPC

Anaemia other/unspecified

3.1

34.4

144

472

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.8

34.1

106

287

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

33.9

907

6145

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.6

33.8

210

851

57198

ICD-8 Finland

Cirrhosis of liver, Alia definita, alcoholismo non indicato

+∞

33.4

L04AA01

ATC

[U] ciclosporin

4.8

33.2

159

A10AD05

ATC

insulin aspart; parenteral

4.1

33.1

234

PC2DE

NOMESCO Finland

Ultrasound examination of liver vasculature with Doppler method

330.4

32.9

ZXE00

NOMESCO Finland

One hour or less

1.6

32.9

1228

9004

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

32.8

232

999

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.9

32.8

155

545

E87.6

ICD-10 Finland

Hypokalaemia

2.9

32.6

157

558

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.5

32.4

111

321

A07EC02

ATC

mesalazine; oral, rectal

2.6

32.2

197

792

AA1AD

NOMESCO Finland

CT of head and brain

1.6

31.9

1028

7270

A08

ICPC

Swelling

2.3

31.6

244

1092

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

2.7

31.5

179

694

JCA20

NOMESCO Finland

Ligature of oesophageal varices

+∞

31.3

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

31.9

31.3

D64.8

ICD-10 Finland

Other specified anaemias

3.8

31.3

267

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

3.9

31.0

241

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

7.5

31.0

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

31.0

513

3031

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.3

30.7

258

1196

N18.8

ICD-10 Finland

Other chronic renal failure

3.4

30.6

114

348

R4190

NOMESCO Finland

Nutritional therapy

2.8

30.6

161

600

PC2ET

NOMESCO Finland

Extensive embolisation of lesion of liver

35.9

30.6

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

6.4

30.3

I50

ICD-10 Finland

Heart failure

3.0

30.3

137

470

K73.0

ICD-10 Finland

Chronic persistent hepatitis, not elsewhere classified

+∞

30.2

K74.4

ICD-10 Finland

Secondary biliary cirrhosis

+∞

30.2

B80

ICPC

Iron deficiency anaemia

3.3

30.1

113

347

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.7

30.1

172

669

JKE32

NOMESCO Finland

Endoscopic dilatation of bile duct

8.9

29.8

N05CF01

ATC

zopiclone; oral

1.6

29.7

1055

7604

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.6

29.6

173

680

K74

ICD-10 Finland

Fibrosis and cirrhosis of liver

+∞

29.2

R02

ICPC

Shortness of breath/dyspnoea

1.8

29.2

488

2888

WX882

NOMESCO Finland

High dependency care

3.1

28.9

124

413

Z3226

NOMESCO Finland

Physiotherapist

1.7

28.7

606

3834

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.3

28.7

226

1020

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

28.5

762

5123

R41.0

ICD-10 Finland

Disorientation, unspecified

2.9

28.1

135

479

D69.3

ICD-10 Finland

Idiopathic thrombocytopenic purpura

6.1

28.1

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.7

27.8

246

JN4BD

NOMESCO Finland

Extensive body CT

1.9

27.8

383

2131

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.4

27.7

103

314

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

27.7

1294

9867

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

27.4

1191

8937

P19

ICPC

Drug abuse

8.3

27.4

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.5

27.3

268

E0000UV, ,

ATC

1.5

27.2

1291

9865

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

10.4

27.1

I85

ICD-10 Finland

Oesophageal varices

+∞

27.1

JJ3AT

NOMESCO Finland

Cytology of liver with ultrasound guidance

38.2

27.1

XCK10

NOMESCO Finland

Photography of fundus of eye

1.9

27.1

346

1877

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

26.8

1042

7625

L28

ICPC

Limited function/disability (L)

1.6

26.8

673

4448

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

26.7

363

2009

A10BJ05

ATC

dulaglutide; parenteral

3.4

26.7

292

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

6.4

26.5

M10.9

ICD-10 Finland

Gout, unspecified

2.1

26.4

284

1449

L01XE05

ATC

[U] sorafenib

29.5

26.3

323

Kela drug reimbursment

Sorafenib

29.5

26.3

RS220, ,

NOMESCO Finland

4.5

26.2

145

K50.8

ICD-10 Finland

Other Crohn disease

4.3

26.0

158

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.4

26.0

183

786

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.1

25.9

111

369

UJF02

NOMESCO Finland

Peroral enteroscopy

6.7

25.9

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.7

25.9

137

512

WX402

NOMESCO Finland

General anaesthesia

1.6

25.9

727

4934

V03AE01

ATC

polystyrene sulfonate; oral

4.2

25.7

164

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

25.5

339

1862

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.8

25.3

133

495

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

6.3

25.3

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

25.2

576

3709

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

25.1

755

5203

L01BB02

ATC

mercaptopurine; oral

5.4

24.9

N05CD07

ATC

temazepam; oral

1.8

24.9

401

2339

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

24.9

868

6183

UJK12

NOMESCO Finland

Peroral cholangioscopy

23.6

24.8

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.2

24.7

205

945

JX1XE

NOMESCO Finland

Other ultrasound examinaton of alimentary organs

43.2

24.6

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

3.5

24.4

239

K07

ICPC

Swollen ankles/oedema

2.3

24.4

190

852

E66.0

ICD-10 Finland

Obesity due to excess calories

4.7

24.3

121

WX419

NOMESCO Finland

Other general anesthesy

5.3

24.2

A10BB01

ATC

glibenclamide; oral

2.6

24.1

145

578

K76.1

ICD-10 Finland

Chronic passive congestion of liver

+∞

24.0

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.9

24.0

117

419

A10AB04

ATC

insulin lispro; parenteral

2.9

23.9

111

387

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

23.7

451

2759

A12BA01

ATC

potassium chloride; oral

2.4

23.7

161

680

J01DB01

ATC

cefalexin; oral

1.6

23.7

2602

23272

SPAT1255

SPAT

Intravenous administration of medicine

2.1

23.6

249

1260

A10AB06

ATC

insulin glulisine; parenteral

4.6

23.6

124

T89

ICPC

Diabetes insulin dependent

2.6

23.6

141

561

XF600

NOMESCO Finland

Bloodpressure measurement

2.1

23.5

227

1112

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

3.2

23.5

311

TK810

NOMESCO Finland

Hemofiltration

6.5

23.5

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

4.5

23.4

125

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

4.7

23.3

117

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

5.7

23.3

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

9.7

23.2

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

5.8

23.2

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.7

23.2

200

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

4.4

23.1

130

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.2

23.1

190

873

D73.1

ICD-10 Finland

Hypersplenism

36.6

23.0

C01AA05

ATC

digoxin; systemic

2.0

23.0

280

1492

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.4

23.0

169

740

K74.1

ICD-10 Finland

Hepatic sclerosis

+∞

22.9

A40.8

ICD-10 Finland

Other streptococcal sepsis

4.5

22.9

127

D62

ICD-10 Finland

Acute posthaemorrhagic anaemia

4.7

22.9

111

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

5.2

22.9

L01EX02

ATC

sorafenib; oral

40.4

22.7

SPAT1088

SPAT

Blood transfusion

6.4

22.6

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

4.2

22.6

141

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.0

22.3

247

1272

A10AE06

ATC

insulin degludec; parenteral

2.6

22.3

129

505

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.2

22.2

201

959

J94.8

ICD-10 Finland

Other specified pleural conditions

3.4

22.2

230

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

4.0

22.2

156

JDA05

NOMESCO Finland

Endoscopic polypectomy in stomach or pylorus

7.6

22.1

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

22.0

511

3295

B01AA03

ATC

warfarin; systemic

1.6

22.0

634

4310

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.9

21.9

162

N05BA04

ATC

oxazepam; oral

1.5

21.8

795

5692

A10BJ01

ATC

exenatide; parenteral

4.4

21.8

128

A07AA09

ATC

vancomycin; oral

3.6

21.7

195

R11

ICD-10 Finland

Nausea and vomiting

1.9

21.7

279

1514

C09AA02

ATC

enalapril; systemic

1.6

21.6

646

4425

K08.3

ICD-10 Finland

Retained dental root

1.9

21.6

281

1531

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.4

21.5

154

666

3A064, ,

NOMESCO Finland

8.3

21.4

C10AB05

ATC

fenofibrate; oral

3.2

21.3

266

E88.0

ICD-10 Finland

Disorders of plasma-protein metabolism, not elsewhere classified

26.6

21.3

D05AX52

ATC

calcipotriol, combinations; topical

2.2

21.3

188

889

K50.9

ICD-10 Finland

Crohn disease, unspecified

4.0

21.3

152

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

4.8

21.3

102

H02AB07

ATC

prednisone; oral

1.7

21.2

438

2736

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

6.0

21.2

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.1

21.2

212

1052

K80.3

ICD-10 Finland

Calculus of bile duct with cholangitis

4.7

21.0

103

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

4.7

20.8

104

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.8

20.7

358

2128

JKD20

NOMESCO Finland

Anastomosis of bile duct to jejunum

77.3

20.7

B01AB05

ATC

enoxaparin; parenteral

1.5

20.6

1016

7717

5761C

ICD-9 Finland

Other disorders of biliary tract, Cholangitis[CHOLANGITIS SCLEROSIVA]

211.3

20.6

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

4.5

20.5

109

A10BH02

ATC

vildagliptin; oral

3.1

20.4

289

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.4

20.3

146

633

3019

Kela drug reimbursment

Lenvatinib

32.7

20.2

JAH01

NOMESCO Finland

Laparoscopy

2.4

20.1

144

623

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

20.1

228

1184

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.4

20.1

136

574

K77

ICPC

Heart failure

2.9

20.0

330

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

3.1

20.0

282

D69.5

ICD-10 Finland

Secondary thrombocytopenia

7.6

20.0

JDA42

NOMESCO Finland

Other endoscopic haemostatic procedure in stomach or pylorus

7.3

19.9

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

19.9

442

2812

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.1

19.9

201

1001

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

3.5

19.9

197

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

4.1

19.9

133

R53

ICD-10 Finland

Malaise and fatigue

1.5

19.9

754

5429

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.4

19.8

133

559

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

2.7

19.8

110

422

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.6

19.8

188

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

4.0

19.8

138

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

4.3

19.7

117

K86.1

ICD-10 Finland

Other chronic pancreatitis

4.5

19.6

105

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.4

19.5

214

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.7

19.5

171

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

19.5

422

2668

C02EA02, ,

ATC

2.3

19.4

149

665

D07AC01

ATC

betamethasone; topical

1.4

19.4

1132

8849

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

0.6

19.3

353

5575

D63.8

ICD-10 Finland

Anaemia in other chronic diseases classified elsewhere

8.4

19.3

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

19.3

303

1751

R16.1

ICD-10 Finland

Splenomegaly, not elsewhere classified

31.5

19.2

1508

Kela drug reimbursment

Lenvatinib

31.5

19.2

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

19.1

151

682

E87.2

ICD-10 Finland

Acidosis

6.1

19.0

R60.1

ICD-10 Finland

Generalized oedema

5.0

19.0

N07BB01

ATC

disulfiram; oral

2.4

19.0

134

576

E000001, ,

ATC

1.6

19.0

568

3880

3A422, ,

NOMESCO Finland

55.3

18.9

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.8

18.9

346

K75.8

ICD-10 Finland

Other specified inflammatory liver diseases

+∞

18.8

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

4.4

18.7

105

C22.1

ICD-10 Finland

Malignant neoplasm: Intrahepatic bile duct carcinoma

6.8

18.7

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.4

18.7

131

562

TKC20

NOMESCO Finland

Catheterisation of bladder

1.9

18.6

233

1252

JAH00

NOMESCO Finland

Laparotomy

2.6

18.5

108

425

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

18.5

1154

9109

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.8

18.4

334

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

18.3

2055

17888

K26.9

ICD-10 Finland

Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation

4.3

18.3

107

K65.9

ICD-10 Finland

Peritonitis, unspecified

13.6

18.2

SPAT1265

SPAT

Breathalyser

4.8

18.2

Z94.0

ICD-10 Finland

Kidney transplant status

4.0

18.1

129

K86.2

ICD-10 Finland

Cyst of pancreas

3.9

18.1

138

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.8

18.1

326

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

5.0

18.1

JKE22

NOMESCO Finland

Endoscopic extraction of foreign body from bile duct

6.3

18.0

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

33.1

17.9

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

17.9

566

3910

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

3.3

17.9

206

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

17.9

422

2724

A11CC03

ATC

alfacalcidol; systemic

2.7

17.8

357

SPAT1254

SPAT

Administration of medicine

1.6

17.8

450

2953

L01EX08

ATC

lenvatinib; oral

26.8

17.8

358

Kela drug reimbursment

liraglutide

5.6

17.7

5719X

ICD-9 Finland

Chronic liver disease and cirrhosis, Unspecified chronic liver disease without mention of alcohol

+∞

17.7

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.8

17.7

303

1794

B03XA02

ATC

darbepoetin alfa; parenteral

2.8

17.7

336

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.3

17.6

198

D25

ICPC

Abdominal distension

3.0

17.5

266

A02BC01

ATC

omeprazole; systemic

1.4

17.5

822

6150

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

15.7

17.5

3AC01, ,

NOMESCO Finland

4.2

17.2

112

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

17.1

771

5719

RD210, ,

NOMESCO Finland

3.2

17.1

212

H3600, E113,

ICD-10 Finland

3.6

17.1

158

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

17.1

326

1990

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

17.1

212

1136

JJ7LT

NOMESCO Finland

Coagulation of focal hepatic lesion under CT guidance

31.6

17.0

XF622

NOMESCO Finland

Measurement of minute volume of heart

6.6

17.0

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.7

16.9

366

2310

K55.2

ICD-10 Finland

Angiodysplasia of colon

5.0

16.9

F05.9

ICD-10 Finland

Delirium, unspecified

2.8

16.9

305

ZZA00

NOMESCO Finland

Split skin graft

2.5

16.8

105

427

D70.89

ICD-10 Finland

Neutropenic splenomegaly

3.6

16.8

155

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

5.7

16.8

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.4

16.7

117

502

5714X

ICD-9 Finland

Chronic liver disease and cirrhosis, Chronic hepatitis[HEPATITIS CHRONICA ALIA SEU NUD]

+∞

16.7

DKW00

NOMESCO Finland

Cauterisation of mucosa of nose

3.9

16.6

124

B18.1

ICD-10 Finland

Chronic viral hepatitis B without delta-agent

12.7

16.6

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

16.6

253

1447

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.0

16.5

238

S76

ICPC

Skin infection other

2.0

16.5

188

979

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.9

16.4

203

1086

B03BA03

ATC

hydroxocobalamin; parenteral

2.0

16.4

189

987

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.6

16.4

153

XX4AT

NOMESCO Finland

Other canalization with ultrasound guidance

5.7

16.3

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

16.3

397

2580

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.2

16.2

142

670

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

5.5

16.2

K51.8

ICD-10 Finland

Other ulcerative colitis

3.4

16.2

169

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

16.1

416

2740

K25.4

ICD-10 Finland

Gastric ulcer, Chronic or unspecified with haemorrhage

4.5

16.1

K02.2

ICD-10 Finland

Caries of cementum

2.0

16.1

169

854

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

3.5

16.1

155

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

16.0

576

4081

UJD10, ,

SPAT

2.5

16.0

100

407

D07AD01

ATC

clobetasol; topical

1.5

15.9

517

3586

JKE18

NOMESCO Finland

Endoscopic internal drainage of bile duct

3.8

15.9

128

K31.7

ICD-10 Finland

Polyp of stomach and duodenum

5.4

15.9

I48.2

ICD-10 Finland

Chronic atrial fibrillation

2.0

15.9

174

893

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

3.4

15.9

171

R03AC02

ATC

salbutamol; inhalant

1.4

15.8

1613

13679

Z72.1

ICD-10 Finland

Alcohol use

3.7

15.8

138

B81

ICPC

Anaemia vit B12/folate deficiency

2.2

15.8

135

631

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

15.8

219

1217

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

15.7

236

1343

PC2SC

NOMESCO Finland

Liver angiography with X-ray

33.5

15.7

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.7

15.7

311

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

15.6

594

4254

5715A

ICD-9 Finland

Chronic liver disease and cirrhosis, Cirrhosis of liver without mention of alcohol

+∞

15.6

K75.3

ICD-10 Finland

Granulomatous hepatitis, not elsewhere classified

+∞

15.6

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.4

15.6

163

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

17.3

15.6

L04AA05

ATC

[U] tacrolimus

22.1

15.5

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

3.6

15.5

140

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.6

15.4

367

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

15.4

473

3241

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.3

15.3

175

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

5.0

15.2

RS120, ,

NOMESCO Finland

11.3

15.2

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.4

15.2

105

448

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

4.9

15.2

M05BA04

ATC

alendronic acid; oral

1.7

15.1

282

1709

N06AX11

ATC

mirtazapine; oral

1.4

14.9

1005

7969

I50.1

ICD-10 Finland

Left ventricular failure

2.0

14.9

171

892

A10BB07

ATC

glipizide; oral

3.6

14.9

139

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

4.0

14.8

107

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

4.3

14.8

M01AB01

ATC

indometacin; systemic, rectal

1.8

14.8

248

1459

H3601, E113,

ICD-10 Finland

3.1

14.7

205

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

3.1

14.7

200

SPAT1263

SPAT

Sampling

1.4

14.7

1193

9737

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

14.6

319

2014

A10AD01

ATC

insulin (human); parenteral

3.2

14.6

180

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

21.1

14.6

C07AB02

ATC

metoprolol; systemic

1.5

14.6

622

4548

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

14.6

1072

8609

N03AX16

ATC

[U] pregabalin

1.4

14.6

697

5207

K75.0

ICD-10 Finland

Abscess of liver

+∞

14.6

57300

ICD-8 Finland

Other diseases of liver, Hepatitis NUD

+∞

14.6

JJC60

NOMESCO Finland

Total excision of transplanted liver

+∞

14.6

K70

ICD-10 Finland

Alcoholic liver disease

80.5

14.6

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

14.5

238

1390

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

14.5

194

1065

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.8

14.5

241

1414

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.1

14.5

202

JJA44

NOMESCO Finland

Laparoscopic destruction of lesion of liver

150.7

14.5

GD1AD

NOMESCO Finland

Thorax CT examination

1.8

14.4

223

1281

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

14.4

504

3545

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

14.4

330

2111

A04

ICPC

Weakness/tiredness general

1.5

14.3

464

3213

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.1

14.3

188

K76.80

ICD-10 Finland

Hepatic cyst

27.3

14.3

N06AB04

ATC

citalopram; systemic

1.5

14.3

589

4281

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

14.2

848

6581

6611

FHL

Needle biopsy in the operating room

22.3

14.2

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

14.1

201

1125

K50.1

ICD-10 Finland

Crohn disease of large intestine

3.9

14.0

107

R03BB04

ATC

tiotropium bromide; inhalant

1.6

14.0

327

2102

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

4.1

13.9

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.6

13.9

308

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.6

13.8

298

1878

K80.8

ICD-10 Finland

Other cholelithiasis

2.8

13.7

236

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.3

13.7

432

WZC30

NOMESCO Finland

Teaching

1.5

13.7

531

3812

K25.3

ICD-10 Finland

Gastric ulcer, Acute without haemorrhage or perforation

3.8

13.5

110

D02AE01

ATC

carbamide; topical

1.8

13.5

190

1061

L17

ICPC

Foot/toe symptom/complaint

1.4

13.5

930

7379

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

13.4

717

5453

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

13.4

658

4930

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

3.8

13.4

106

EBA00

NOMESCO Finland

Extraction of tooth

1.3

13.4

1050

8493

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

12.9

13.4

XQ841

NOMESCO Finland

Examination of dermatosis with microscope

18.3

13.4

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

18.3

13.4

C03AA03

ATC

hydrochlorothiazide; oral

1.6

13.4

288

1813

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.7

13.3

111

TGC00

NOMESCO Finland

Bronchial lavation

2.4

13.3

399

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

4.5

13.3

J01DA01

ATC

[U] cefalexin

1.3

13.3

1806

15801

S18

ICPC

Laceration/cut

1.3

13.3

1484

12633

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

2.2

13.2

108

496

JDA32

NOMESCO Finland

Endoscopic injection in stomach or pylorus

9.7

13.2

H02AB09

ATC

hydrocortisone; systemic

2.5

13.2

340

A10BX02

ATC

repaglinide; oral

3.1

13.2

171

JA3GT

NOMESCO Finland

Insertion of tunnelled ascites drain

40.2

13.1

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.2

13.1

156

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

13.0

165

891

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

13.0

253

1552

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

5.2

13.0

C08CA01

ATC

amlodipine; oral

1.3

12.9

1252

10433

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.9

12.9

172

944

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.5

12.9

128

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

3.4

12.9

133

T74.1

ICD-10 Finland

Physical abuse

3.2

12.9

153

N05BA01

ATC

diazepam; systemic, rectal

1.5

12.8

374

2527

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

12.8

144

746

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.8

12.8

180

1004

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

2.6

12.8

279

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.6

12.8

336

2217

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

12.8

592

4387

K29.2

ICD-10 Finland

Alcoholic gastritis

11.6

12.8

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

2.6

12.8

297

P01AB01

ATC

metronidazole; oral, rectal

1.3

12.8

1131

9299

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

5.1

12.7

ZY010

NOMESCO Finland

Hospital outpatient

2.0

12.7

134

680

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

12.6

210

1232

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

12.6

465

3299

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.7

12.6

106

N30.0

ICD-10 Finland

Acute cystitis

1.5

12.6

475

3385

ZXE90

NOMESCO Finland

More than 22 hours

4.8

12.6

R06AE07

ATC

cetirizine; oral

1.3

12.6

1204

10006

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.0

12.5

140

724

A10BG02

ATC

rosiglitazone; oral

2.9

12.5

203

H36.01

ICD-10 Finland

Diabetic maculopathy

3.1

12.5

171

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.6

12.5

265

D50

ICD-10 Finland

Iron deficiency anaemia

2.6

12.5

265

K71.9

ICD-10 Finland

Toxic liver disease, unspecified

+∞

12.5

5718X

ICD-9 Finland

Chronic liver disease and cirrhosis, Other chronic nonalcoholic liver disease

+∞

12.5

5714B

ICD-9 Finland

Chronic liver disease and cirrhosis, Chronic hepatitis[HEPATITIS CHRONICA ACTIVA (HBSAG-)]

+∞

12.5

K73.89

ICD-10 Finland

Other long-term hepatitis, not classified differently

+∞

12.5

K26.0

ICD-10 Finland

Duodenal ulcer, acute with haemorrhage

4.0

12.4

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.9

12.3

151

806

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

3.2

12.3

152

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

2.1

12.2

118

579

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.9

12.2

145

766

A40.9

ICD-10 Finland

Streptococcal sepsis, unspecified

9.7

12.2

Z72.2

ICD-10 Finland

Drug use

9.7

12.2

WX213

NOMESCO Finland

Lower leg blockade

3.7

12.2

104

A02BC05

ATC

esomeprazole; systemic

1.3

12.2

1204

10038

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

3.3

12.2

133

N05AH04

ATC

quetiapine; oral

1.5

12.2

458

3263

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.3

12.2

378

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.6

12.1

281

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

12.1

104

488

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.1

12.1

120

595

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

12.1

301

1962

C09AA05

ATC

ramipril; oral

1.4

12.1

787

6171

JKA20

NOMESCO Finland

Cholecystectomy

2.3

12.1

392

D05AX02

ATC

calcipotriol; topical

2.1

12.1

119

589

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

12.0

820

6472

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.6

12.0

255

1598

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

13.4

11.9

E86

ICD-10 Finland

Volume depletion

2.3

11.9

394

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

11.9

367

2510

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

4.7

11.9

L04AA10

ATC

[U] sirolimus

46.8

11.9

474, ,

NOMESCO Finland

46.8

11.9

D07XC01

ATC

betamethasone; topical

1.5

11.7

363

2484

K05.31

ICD-10 Finland

Periodontitis pronounced

1.5

11.7

353

2402

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

3.1

11.7

157

JCA42

NOMESCO Finland

Other endoscopic procedure for hemostasis

16.5

11.7

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

3.4

11.7

117

WPB10

NOMESCO Finland

Making a convalescent care decision

4.8

11.6

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.2

11.6

464

K29.4

ICD-10 Finland

Chronic atrophic gastritis

2.5

11.6

276

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.5

11.5

294

P16

ICPC

Acute alcohol abuse

3.0

11.5

169

Z94.1

ICD-10 Finland

Heart transplant status

11.1

11.5

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

11.5

218

1328

57308

ICD-8 Finland

Other diseases of liver, Alii definiti

+∞

11.5

K76.4

ICD-10 Finland

Peliosis hepatis

+∞

11.5

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

3.9

11.4

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

1.7

11.4

191

1125

H03AA01

ATC

levothyroxine sodium; systemic

1.4

11.4

645

4941

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.0

11.3

160

L29.9

ICD-10 Finland

Pruritus, unspecified

2.2

11.3

403

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

3.1

11.3

145

A10BD03

ATC

metformin and rosiglitazone; systemic

2.7

11.2

227

E000006, ,

ATC

1.7

11.2

187

1098

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.2

11.2

457

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.2

11.2

457

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

4.5

11.2

K85

ICD-10 Finland

Acute pancreatitis

2.8

11.2

205

V03AE02

ATC

sevelamer; oral

4.6

11.2

M10.0

ICD-10 Finland

Idiopathic gout

2.0

11.2

123

634

WW200

NOMESCO Finland

Immunization

2.3

11.2

380

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

12.7

11.1

JDA22

NOMESCO Finland

Endoscopic ligature of varices of stomach

20.1

11.1

TPH04, ,

SPAT

3.1

11.1

141

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

3.0

11.1

157

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

11.1

379

2648

K65.8

ICD-10 Finland

Other peritonitis

8.1

11.1

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.3

11.0

369

OAB50, ,

SPAT

1.6

11.0

256

1643

SPAT1229

SPAT

Assessment of need for aid

1.6

11.0

235

1477

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

11.0

141

766

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.1

10.9

455

L28.1

ICD-10 Finland

Prurigo nodularis

3.8

10.9

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.8

10.9

166

950

WW200, ,

SPAT

0.7

10.9

579

7487

H26.3

ICD-10 Finland

Drug-induced cataract

4.1

10.9

NHQ40

NOMESCO Finland

Amputation of toe

2.8

10.9

197

SPAT1281

SPAT

Other administrative function

1.7

10.9

220

1363

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.6

10.8

246

1569

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

4.3

10.8

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

2.3

10.8

329

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.8

10.7

158

895

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

10.7

140

764

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

2.3

10.7

342

B17.1

ICD-10 Finland

Acute hepatitis C

28.1

10.7

R77.0

ICD-10 Finland

Abnormality of albumin

17.9

10.7

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1.9

10.7

131

700

RJ410, ,

NOMESCO Finland

5.6

10.7

A07AA02

ATC

nystatin; oral

1.8

10.6

173

1011

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

10.6

534

4007

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

8.5

10.5

B01AB04

ATC

dalteparin; parenteral

1.8

10.4

150

844

I98.2

ICD-10 Finland

Oesophageal varices without bleeding in diseases classified elsewhere

+∞

10.4

K73.8

ICD-10 Finland

Other chronic hepatitis, not elsewhere classified

+∞

10.4

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

10.4

209

1292

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

3.7

10.4

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.8

10.4

141

780

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

10.4

2103

19082

A03

ICPC

Fever

1.4

10.3

418

3016

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.4

10.3

274

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.0

10.3

148

R74.9

ICD-10 Finland

Abnormal level of unspecified serum enzyme

4.4

10.3

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

2.5

10.3

256

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.6

10.2

254

1656

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

10.2

206

1276

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.3

10.2

350

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

10.2

543

4111

K11.70

ICD-10 Finland

Hypoptyalism

4.1

10.1

SPAT1216

SPAT

Assessment of functional ability

1.4

10.1

459

3379

R06

ICPC

Nose bleed/epistaxis

2.2

10.1

377

RS221, ,

NOMESCO Finland

2.8

10.1

177

C10AA07

ATC

rosuvastatin; oral

0.8

10.0

723

8957

Z71.4

ICD-10 Finland

Alcohol abuse counselling and surveillance

4.5

10.0

D77

ICPC

Malignant digestive neopl other/NOS

4.5

10.0

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

4.8

10.0

M81.8

ICD-10 Finland

Other osteoporosis

3.2

10.0

124

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

10.0

1051

8779

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.0

10.0

108

554

L30.3

ICD-10 Finland

Infective dermatitis

2.0

9.9

103

520

JAF10

NOMESCO Finland

Repair of umbilical hernia

2.2

9.9

360

J01CE08

ATC

benzathine benzylpenicillin; parenteral

3.1

9.9

135

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.6

9.9

207

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.8

9.9

145

821

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

2.4

9.9

279

5739X

ICD-9 Finland

Other disorders of liver, Unspecified disorder of liver

16.7

9.9

JKE25

NOMESCO Finland

Endoscopic external drainage of bile duct

5.2

9.8

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

2.6

9.8

208

K02.1

ICD-10 Finland

Caries of dentine

1.3

9.8

1638

14467

ZX120, ,

SPAT

2.8

9.8

174

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.9

9.8

114

600

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

8.7

9.8

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

4.5

9.8

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

3.8

9.8

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.2

9.8

389

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

9.7

1483

12955

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

9.6

544

4155

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.1

9.6

398

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

1.8

9.6

146

836

N06AX16

ATC

venlafaxine; oral

1.5

9.6

361

2567

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

3.7

9.6

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.3

9.6

107

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

9.5

266

1779

321

Kela drug reimbursment

Paricalcitol and cinacalcet

3.6

9.5

EBA10

NOMESCO Finland

Operative extraction of tooth

1.5

9.5

279

1886

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

4.6

9.5

RS122, ,

NOMESCO Finland

9.1

9.5

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

7.1

9.5

NGQ20

NOMESCO Finland

Amputation of lower leg

4.1

9.4

K75.2

ICD-10 Finland

Nonspecific reactive hepatitis

100.3

9.4

C22

ICD-10 Finland

Malignant neoplasm of liver and intrahepatic bile ducts

100.3

9.4

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

3.9

9.4

D23

ICPC

Hepatomegaly

30.1

9.4

JKE12

NOMESCO Finland

Endoscopic extraction of calculus from bile duct

2.8

9.4

167

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.7

9.4

181

1108

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.9

9.4

122

666

JJ9AT

NOMESCO Finland

Sampling of liver transplant under radiological guidance

+∞

9.4

RJ411, ,

NOMESCO Finland

4.2

9.4

G03FA14

ATC

dydrogesterone and estrogen; systemic

0.4

9.3

1016

J02AC01

ATC

fluconazole; systemic

1.3

9.3

1004

8395

RJ421, ,

NOMESCO Finland

4.9

9.3

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.1

9.3

437

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

3.8

9.2

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.4

9.2

251

XPX08

NOMESCO Finland

Intraoperative flow measurement

3.1

9.2

120

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

9.2

234

1534

N05BA12

ATC

alprazolam; oral

1.5

9.2

273

1852

M10

ICD-10 Finland

Gout

1.8

9.1

143

826

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.8

9.1

145

841

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

3.9

9.1

J04AB02

ATC

rifampicin; systemic

2.8

9.1

164

A12AA04

ATC

calcium carbonate; oral

2.5

9.1

216

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

3.6

9.1

R80

ICD-10 Finland

Isolated proteinuria

3.6

9.1

N03AX14

ATC

levetiracetam; systemic

2.1

9.1

407

D07AC13

ATC

mometasone; topical

1.3

9.1

809

6596

K81.9

ICD-10 Finland

Cholecystitis, unspecified

3.1

9.1

121

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.0

9.1

482

V03AA01, ,

ATC

2.6

9.1

193

N06AX03

ATC

mianserin; oral

1.8

9.1

136

776

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

4.8

9.1

KGH10

NOMESCO Finland

Operation for phimosis

2.1

9.1

381

E000003, ,

ATC

1.9

9.1

113

609

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

2.1

9.0

408

A29

ICPC

General symptom/complaint other

1.4

9.0

393

2870

D07AA02

ATC

hydrocortisone; topical

1.5

9.0

343

2444

TJA00

NOMESCO Finland

Puncture of peritoneum

36.8

9.0

I78.8

ICD-10 Finland

Other diseases of capillaries

9.0

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

10.0

9.0

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

2.7

9.0

171

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

2.1

8.9

430

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.1

8.9

117

C08CA02

ATC

felodipine; oral

1.5

8.9

285

1962

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

7.4

8.9

K80

ICD-10 Finland

Cholelithiasis

2.8

8.9

155

M01AH05

ATC

etoricoxib; oral

0.8

8.9

1468

16503

K80.1

ICD-10 Finland

Calculus of gallbladder with other cholecystitis

2.2

8.9

325

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.3

8.9

293

WPA13

NOMESCO Finland

Palliative consultation

3.9

8.9

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

8.8

466

E13.8

ICD-10 Finland

Other specified diabetes mellitus, with unspecified complications

8.0

8.8

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

6.8

8.8

SPAT1211

SPAT

Application of soft bandage

1.5

8.8

241

1605

207

Kela drug reimbursment

Chronic arrhythmias

1.4

8.8

495

3773

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.8

8.8

126

709

W19

ICD-10 Finland

Unspecified fall

1.5

8.8

274

1876

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.3

8.8

572

4460

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.6

8.8

200

1277

2BD01, ,

NOMESCO Finland

10.7

8.8

K22.6

ICD-10 Finland

Gastro-oesophageal laceration-haemorrhage syndrome

3.8

8.8

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

8.8

1057

8946

N05AA02

ATC

levomepromazine; systemic

1.9

8.8

109

587

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.2

8.8

314

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.7

8.8

170

1043

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

3.4

8.7

A10AB01

ATC

insulin (human); parenteral

2.1

8.7

420

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.3

8.7

276

SPAT1251

SPAT

Organisation of medication

2.0

8.7

489

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.3

8.7

289

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

8.7

975

8178

C01DA14

ATC

isosorbide mononitrate; oral

1.4

8.7

457

3446

212

Kela drug reimbursment

Gout

2.3

8.7

283

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

8.7

292

2031

A02BA03

ATC

famotidine; systemic

1.9

8.7

109

589

3044A

ICD-9 Finland

Drug dependence, Amphetamine and other psychostimulant dependence

50.1

8.7

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

8.7

242

1619

N02AC04

ATC

dextropropoxyphene; oral

1.9

8.7

106

568

A02BC03

ATC

lansoprazole; oral

1.3

8.7

828

6808

T31

ICPC

Metabolic, Medical examin/health eval partial

3.4

8.6

K86.3

ICD-10 Finland

Pseudocyst of pancreas

4.4

8.6

L84

ICD-10 Finland

Corns and callosities

1.9

8.6

105

562

N03AX12

ATC

[U] gabapentin; oral

1.4

8.6

456

3443

WVA20, ,

SPAT

1.9

8.6

110

598

318

Kela drug reimbursment

Teriparatide

4.0

8.6

K26.7

ICD-10 Finland

Duodenal ulcer, chronic without haemorrhage or perforation

4.6

8.6

S29

ICPC

Skin symptom/complaint other

1.3

8.6

591

4646

J01AA02

ATC

doxycycline; systemic

1.3

8.6

2368

22011

R31

ICD-10 Finland

Unspecified haematuria

1.5

8.6

310

2188

XG410

NOMESCO Finland

Flow-volume spirometry

1.8

8.5

114

628

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

8.5

265

1814

XF612

NOMESCO Finland

Measurement of central venous pressure

9.0

8.5

EB1WA, ,

NOMESCO Finland

3.8

8.5

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.0

8.5

425

K51

ICD-10 Finland

Ulcerative colitis

3.2

8.5

100

N05AB01

ATC

dixyrazine; systemic

2.9

8.5

137

F19.30

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated

20.1

8.5

D05BB02

ATC

acitretin; oral

2.1

8.4

352

K81.0

ICD-10 Finland

Acute cholecystitis

2.3

8.4

287

JJA24

NOMESCO Finland

Laparoscopic needle biopsy of liver

90.3

8.4

JCA35

NOMESCO Finland

Endoscopic contact coagulation in oesophagus

90.3

8.4

C08CA05

ATC

nifedipine; systemic

1.6

8.4

171

1062

SPAT1301

SPAT

No procedures

1.3

8.4

862

7148

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

2.5

8.4

207

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

3.1

8.4

106

PD1AD

NOMESCO Finland

CT of abdominal aorta and branches

3.2

8.3

101

K71.2

ICD-10 Finland

Toxic liver disease with acute hepatitis

+∞

8.3

6615

FHL

Liver transplant

+∞

8.3

391

Kela drug reimbursment

Obeticholic acid

+∞

8.3

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

8.3

1056

8983

EBA30

NOMESCO Finland

Extraction of root of tooth

1.6

8.3

181

1145

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.8

8.3

125

716

N05BA02

ATC

chlordiazepoxide; systemic

2.2

8.3

322

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

3.8

8.2

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.7

8.2

136

799

R04.2

ICD-10 Finland

Haemoptysis

1.9

8.2

106

578

L40.9

ICD-10 Finland

Psoriasis, unspecified

2.5

8.2

197

B02AA02

ATC

tranexamic acid; systemic

1.4

8.2

351

2555

L40.8

ICD-10 Finland

Other psoriasis

3.3

8.2

A08AB01

ATC

orlistat; oral

3.3

8.2

A41.2

ICD-10 Finland

Sepsis due to unspecified staphylococcus

14.5

8.2

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

6.5

8.2

R10.0

ICD-10 Finland

Acute abdomen

2.0

8.2

466

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.9

8.2

103

558

M81.4

ICD-10 Finland

Drug-induced osteoporosis

3.9

8.1

G41.9

ICD-10 Finland

Status epilepticus, unspecified

4.4

8.1

SPAT1252

SPAT

Overall medication plan or its review

1.6

8.1

192

1237

K50.0

ICD-10 Finland

Crohn disease of small intestine

2.7

8.1

163

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

2.9

8.1

124

N18.0

ICD-10 Finland

End-stage renal disease

2.9

8.1

124

K02.9

ICD-10 Finland

Dental caries, unspecified

2.4

8.1

229

SPAT1260

SPAT

Consultation of another employee

1.4

8.1

475

3644

2BB01, ,

NOMESCO Finland

33.4

8.1

0705A

ICD-9 Finland

Viral hepatitis, Other specified viral hepatitis without mention of hepatic coma

33.4

8.1

K29.8

ICD-10 Finland

Duodenitis

3.2

8.1

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

8.1

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

3.0

8.1

119

P01BA02

ATC

hydroxychloroquine; oral

1.5

8.1

221

1473

SPAT1269

SPAT

Other puncture and/or drainage

3.8

8.1

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

8.1

508

3939

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.7

8.1

153

934

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

2.6

8.0

164

5AB14, ,

NOMESCO Finland

10.0

8.0

Z71.9

ICD-10 Finland

Counselling, unspecified

1.5

8.0

219

1459

RS321, ,

NOMESCO Finland

22.1

8.0

AN1

Coronary angiography

1.4

8.0

327

2361

L40

ICD-10 Finland

Psoriasis

2.3

8.0

268

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.8

8.0

564

7048

5BA08, ,

NOMESCO Finland

3.9

8.0

A10

ICPC

Bleeding/haemorrhage NOS

3.2

7.9

130

Kela drug reimbursment

Malignant tumour

1.5

7.9

272

1901

A10BD08

ATC

metformin and vildagliptin; systemic

3.0

7.9

110

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

3.9

7.9

ZJX00

NOMESCO Finland

Double balloon technique in gastroenterological endoscopy

13.0

7.9

Z71.8

ICD-10 Finland

Other specified counselling

1.3

7.9

912

7665

WX730

NOMESCO Finland

Conventional respirator

2.5

7.8

190

J94.9

ICD-10 Finland

Pleural condition, unspecified

3.8

7.8

D13

ICPC

Jaundice

10.8

7.8

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

1.9

7.8

467

M34.9

ICD-10 Finland

Systemic sclerosis, unspecified

7.0

7.8

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

7.0

7.8

TBW99

NOMESCO Finland

Other minor procedure in endocrine surgery

7.0

7.8

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

7.0

7.8

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.4

7.8

215

N05CF02

ATC

zolpidem; oral

1.4

7.7

459

3525

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

7.7

751

6174

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.9

7.7

532

1370

FHL

Colonoscopy, whole colon

4.2

7.7

SPAT1122

SPAT

Ascites puncture

45.1

7.7

OAA67, ,

SPAT

0.6

7.7

165

2544

XF602

NOMESCO Finland

Bloodpressure monitoring

2.6

7.7

162

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.7

7.7

132

785

C09BA02

ATC

enalapril and diuretics; systemic

1.5

7.7

234

1597

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

2.1

7.7

359

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

2.5

7.7

180

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

2.5

7.7

186

ZXD35

NOMESCO Finland

Usual procedure

1.9

7.6

456

N06AA09

ATC

amitriptyline; systemic

1.5

7.6

266

1864

A63.0

ICD-10 Finland

Anogenital (venereal) warts

2.2

7.6

293

A98

ICPC

Health maint/preventive medicine

0.7

7.6

2845

29460

H26.02

ICD-10 Finland

Presenil cataract

2.0

7.6

401

SAA04

NOMESCO Finland

Special examination of mouth

1.7

7.6

135

810

OAB43, ,

SPAT

0.7

7.6

337

4516

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.9

7.6

493

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.7

7.6

124

728

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.8

7.5

107

602

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

7.5

620

4988

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

3.8

7.5

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

4.2

7.5

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

7.4

134

807

4560A

ICD-9 Finland

Varicose veins of other sites, Oesophageal varices with bleeding

80.3

7.4

4AA09, ,

NOMESCO Finland

80.3

7.4

L04AA18

ATC

[U] everolimus

80.3

7.4

QDA10

NOMESCO Finland

Incision of skin of lower limb

3.2

7.4

1280

FHL

Endoscopic retrograde cholangiography and pancreaticography

13.4

7.4

K86.01

ICD-10 Finland

Late effects of pancreatitis caused by alcohol

7.7

7.4

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

4.0

7.3

XX4BW, ,

NOMESCO Finland

8.4

7.3

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.7

7.3

132

796

N40

ICD-10 Finland

Hyperplasia of prostate

0.7

7.3

445

5685

I44.2

ICD-10 Finland

Atrioventricular block, complete

1.9

7.3

449

S42.0

ICD-10 Finland

Fracture of clavicle

2.0

7.3

407

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.0

7.3

407

N06DA02

ATC

donepezil; oral

0.5

7.3

1155

A05AA04

ATC

obeticholic acid; oral

+∞

7.3

57100

ICD-8 Finland

Cirrhosis of liver, Cirrhosis cum alcoholismo

+∞

7.3

5711A

ICD-9 Finland

Chronic liver disease and cirrhosis, Acute alcoholic hepatitis

+∞

7.3

K76.5

ICD-10 Finland

Hepatic veno-occlusive disease

+∞

7.3

5761A

ICD-9 Finland

Other disorders of biliary tract, Cholangitis[CHOLANGITIS SUPPURATIVA]

+∞

7.3

L04AH02

ATC

everolimus; oral

+∞

7.3

602

Kela drug reimbursment

Children's severe malnutrition

9.4

7.3

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

4.1

7.3

G63.2

ICD-10 Finland

Diabetic polyneuropathy

4.1

7.3

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

7.3

830

6953

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.6

7.3

124

2016

H05BX01

ATC

cinacalcet; oral

3.4

7.2

N06AB10

ATC

escitalopram; oral

1.3

7.2

476

3711

DKW30

NOMESCO Finland

Cauterisation of artery of internal nose

3.3

7.2

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

7.2

380

2863

T82

ICPC

Obesity

1.8

7.2

552

I95.2

ICD-10 Finland

Hypotension due to drugs

3.0

7.2

100

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

2.7

7.2

133

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.5

7.2

226

1553

T93

ICPC

Lipid disorder

0.6

7.2

1562

K86.9

ICD-10 Finland

Disease of pancreas, unspecified

3.9

7.2

R52.0

ICD-10 Finland

Acute pain

1.9

7.2

488

JJA43

NOMESCO Finland

Destruction of lesion of liver

30.1

7.1

CL2S4, ,

SPAT

2.0

7.1

355

C07AB03

ATC

atenolol; systemic

1.6

7.1

167

1076

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.9

7.1

482

F60.2

ICD-10 Finland

Dissocial personality disorder

7.9

7.1

H05AA02

ATC

teriparatide; parenteral

3.8

7.1

A10BX01

ATC

guar gum; oral

1.8

7.1

108

622

176

Kela drug reimbursment

Regorafenib

5.6

7.1

D07AB08

ATC

desonide; topical

1.4

7.0

272

1944

107

Kela drug reimbursment

Pernicious anaemia

2.2

7.0

257

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.6

7.0

177

1159

JDA35

NOMESCO Finland

Endoscopic contact coagulation in stomach or pylorus

10.0

7.0

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

2.9

7.0

107

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

2.6

7.0

141

B01AB10

ATC

tinzaparin; parenteral

1.4

7.0

316

2324

K03.66

ICD-10 Finland

Tooth plaque

1.5

7.0

212

1447

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

2.4

6.9

183

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

6.9

323

2387

M05BA07

ATC

risedronic acid; oral

1.9

6.9

423

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.6

6.9

138

856

S01.0

ICD-10 Finland

Open wound of scalp

1.5

6.9

225

1558

SPE90

NOMESCO Finland

Other partial denture

2.0

6.9

333

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.1

6.9

D09AB01

ATC

zinc bandage without supplements; topical

2.1

6.9

273

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.5

6.9

231

1609

A01AB09

ATC

miconazole; local oral

1.5

6.8

220

1518

WX890

NOMESCO Finland

Intesive care monitoring

3.5

6.8

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.1

6.8

280

K63.5

ICD-10 Finland

Polyp of colon

1.9

6.8

389

ED1AA

NOMESCO Finland

Mandibular X-ray examination

3.3

6.8

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

3.3

6.8

D59.9

ICD-10 Finland

Acquired haemolytic anaemia, unspecified

8.3

6.8

288

Kela drug reimbursment

Febuxostat

4.1

6.8

T88.8

ICD-10 Finland

Other specified complications of surgical and medical care, not elsewhere classified

3.8

6.8

F15.5

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder

10.9

6.8

N06AB03

ATC

fluoxetine; oral

1.4

6.8

308

2265

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.1

6.8

294

B37.08

ICD-10 Finland

Other candidal stomatitis

2.9

6.8

109

J01XC01

ATC

fusidic acid; systemic

2.6

6.8

149

R4180

NOMESCO Finland

Podiatric therapy

2.4

6.8

179

N05BB01

ATC

hydroxyzine; systemic

1.6

6.8

149

946

G92

ICD-10 Finland

Toxic encephalopathy

16.7

6.7

D02AX

ATC

Other emollients and protectives

1.9

6.7

398

J01CF05

ATC

flucloxacillin; systemic

1.5

6.7

191

1285

K22.1

ICD-10 Finland

Ulcer of oesophagus

2.3

6.7

217

H3602, E113,

ICD-10 Finland

7.2

6.7

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

2.5

6.7

156

JL5AM

NOMESCO Finland

Bile and pancreas ducts simple MRI examination with 3 Tesla magnet

22.6

6.7

R16.2

ICD-10 Finland

Hepatomegaly with splenomegaly, not elsewhere classified

22.6

6.7

N06AA12

ATC

doxepin; systemic

1.6

6.7

138

863

XA400

NOMESCO Finland

EEG

3.7

6.6

742, ,

NOMESCO Finland

6.4

6.6

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

4.0

6.6

R79.8

ICD-10 Finland

Other specified abnormal findings of blood chemistry

3.1

6.6

L71.9

ICD-10 Finland

Rosacea, unspecified

2.0

6.6

359

G47.3

ICD-10 Finland

Sleep apnoea

1.3

6.6

663

5463

3049X

ICD-9 Finland

Drug dependence, Unspecified drug dependence

12.3

6.6

WX203

NOMESCO Finland

Infraclavicular plexus blockade

2.0

6.6

325

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.8

6.6

473

XX2RW, ,

NOMESCO Finland

2.3

6.6

194

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.1

6.6

305

3025

Kela drug reimbursment

Calcium carbonate

3.3

6.5

SBA00

NOMESCO Finland

Microbiological examinations

2.0

6.5

367

L85.3

ICD-10 Finland

Xerosis cutis

2.6

6.5

140

J01DA06

ATC

[U] cefuroxime

1.4

6.5

360

2733

R40.2

ICD-10 Finland

Coma, unspecified

2.8

6.5

106

D01

ICPC

Abdominal pain/cramps general

1.4

6.5

301

2221

B37.8

ICD-10 Finland

Candidiasis of other sites

6.2

6.5

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

6.2

6.5

377

Kela drug reimbursment

Apremilast and dimethyl fumarate (psoriasis)

5.7

6.4

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

5.7

6.4

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

5.7

6.4

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

6.4

223

1562

ZX196, ,

NOMESCO Finland

70.0

6.4

Q20.48

ICD-10 Finland

Single ventricle

70.0

6.4

E72.2

ICD-10 Finland

Disorders of urea cycle metabolism

70.0

6.4

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

6.4

743

6222

N05BE01

ATC

buspirone; oral

1.9

6.4

377

S82.8

ICD-10 Finland

Fractures of other parts of lower leg

1.8

6.4

573

B19.9

ICD-10 Finland

Unspecified viral hepatitis without hepatic coma

14.3

6.4

SPAT1139

SPAT

Nutrition survey

1.8

6.4

492

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

1.7

6.4

119

725

I73.0

ICD-10 Finland

Raynaud syndrome

2.3

6.4

203

S22.3

ICD-10 Finland

Fracture of rib

1.5

6.4

205

1416

S20

ICPC

Corn/callosity

2.0

6.4

336

FM1DE, ,

SPAT

3.7

6.4

196

Kela drug reimbursment

Paricalcitol and cinacalcet

3.7

6.4

K29.1

ICD-10 Finland

Other acute gastritis

2.4

6.4

166

E16.0

ICD-10 Finland

Drug-induced hypoglycaemia without coma

4.1

6.3

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

3.0

6.3

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

8.2

6.3

M00.0

ICD-10 Finland

Staphylococcal arthritis and polyarthritis

8.2

6.3

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

2.1

6.3

249

J45.8

ICD-10 Finland

Mixed asthma

1.8

6.3

443

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

6.3

1038

9021

M46.4

ICD-10 Finland

Discitis, unspecified

3.6

6.3

N06DX01

ATC

memantine; oral

0.6

6.3

1456

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.3

6.3

204

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.4

6.3

241

1720

UKC02

NOMESCO Finland

Cystoscopy

1.3

6.3

464

3673

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.8

6.3

458

ZXF05

NOMESCO Finland

Interruption of procedure for other patient related reason

3.2

6.3

D94

ICPC

Chronic enteritis/ulcerative colitis

3.2

6.3

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.2

6.3

XW5WT

NOMESCO Finland

Other blood specimen with radiologicl guidance

9.3

6.3

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

2.5

6.3

143

5710A

ICD-9 Finland

Chronic liver disease and cirrhosis, Alcoholic fatty liver

+∞

6.3

K77.0*B25.1

ICD-10 Finland

Cytomegaloviral hepatitis

+∞

6.3

57301

ICD-8 Finland

Other diseases of liver, Degeneratio hepatica NUD

+∞

6.3

K73.1

ICD-10 Finland

Chronic lobular hepatitis, not elsewhere classified

+∞

6.3

PH3YT

NOMESCO Finland

Insertion of catheter from portal vein to liver vein (TIPS)

+∞

6.3

WX199

NOMESCO Finland

Other local analgesia

1.7

6.2

100

585

QDB10, ,

SPAT

1.8

6.2

445

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.3

6.2

374

2877

L01BB01, ,

ATC

7.0

6.2

PD4AD

NOMESCO Finland

CT of lower extremity arteries

2.8

6.2

109

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.6

6.2

138

879

B07.9

ICD-10 Finland

Verruca simplex

1.8

6.2

504

S20.2

ICD-10 Finland

Contusion of thorax

1.6

6.2

145

935

R03AC03

ATC

terbutaline; inhalant

1.4

6.2

347

2643

S10

ICPC

Boil/carbuncle

1.5

6.1

157

1033

Z53.0

ICD-10 Finland

Procedure not carried out because of contraindication

5.7

6.1

K78

ICPC

Atrial fibrillation/flutter

1.4

6.1

224

1586

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.6

6.1

141

906

JJB71

NOMESCO Finland

Laparoscopic resection of liver

7.7

6.1

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

6.1

257

1866

SPAT1104

SPAT

Monitoring of emergency patient

1.5

6.1

176

1189

LCA06

NOMESCO Finland

Biopsy of endometrium

1.4

6.1

257

1867

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

6.1

541

4388

R74

ICD-10 Finland

Abnormal serum enzyme levels

4.1

6.1

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

6.1

528

4270

SPAT1172

SPAT

Guidance concerning hydration

2.0

6.1

321

H25.8

ICD-10 Finland

Other senile cataract

1.4

6.1

321

2421

ZYC01

NOMESCO Finland

Remote contact by phone

1.5

6.1

157

1036

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

8.6

6.0

D61.9

ICD-10 Finland

Aplastic anaemia, unspecified

8.6

6.0

EB4VA, ,

NOMESCO Finland

0.7

6.0

238

3258

E66

ICD-10 Finland

Obesity

1.6

6.0

123

767

J01FA06

ATC

roxithromycin; oral

1.2

6.0

1086

9513

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

2.2

6.0

234

FFM32

NOMESCO Finland

Occlusion or excision of atrial appendage transvenously with a closing device

10.0

6.0

N02BF02

ATC

pregabalin; oral

1.5

6.0

178

1209

TJK00

NOMESCO Finland

Intraoperative cholangiography

3.2

6.0

A40.1

ICD-10 Finland

Sepsis due to streptococcus, group B

5.2

6.0

WPA11

NOMESCO Finland

Developing a plan for palliative care

5.2

6.0

SPAT1247

SPAT

Outpatient detoxication and monitoring

5.2

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(4281824) Cell count and differential, peritoneal fluid

318

270

12.94

318.41

1.4

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

403

484

9.36

316.33

1.3

1.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1743

4506

7.15

307.65

3.5

2.7

23.76

22.17

3.25

1682

4198

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1599

3012

9.45

307.65

1.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2439

9618

7.08

307.65

10.1

3.1

47.44

33.24

u/l

23.18

2383

9066

(44816559) Phosphatidylethanol [Mass/volume] in Blood

891

993

11.97

307.65

2.3

1.5

0.34

0.33

mg/l

0.08

352

475

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1076

293

54.29

307.65

3.8

2.0

1265.98

163.82

u/ml

0.67

1062

288

(3037522) Nuclear Ab [Titer] in Serum

1721

3716

8.68

307.65

1.6

1.3

837.18

510.34

titre

6.21

496

787

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1167

2912

5.68

307.65

2.3

1.7

1.66

1.50

8.73

974

2537

(3034770) Mitochondria Ab [Titer] in Serum

1562

489

60.34

307.65

1.4

1.1

1061.54

801.25

titre

—

214

(3017143) Hepatitis C virus Ab [Presence] in Serum

1477

2568

9.68

307.65

1.6

—

(3044007) Cell count panel - Peritoneal fluid

340

59.19

307.65

2.4

1.6

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

830

241

45.84

307.65

1.2

1.1

1.63

1.51

g/l

4.08

767

223

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

205

52.01

307.65

3.8

1.3

320.32

4.33

ug/l

0.86

205

(3028026) IgM [Mass/volume] in Serum or Plasma

1676

1529

21.47

307.65

1.8

2.1

1.82

1.36

g/l

6.19

1573

1403

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

406

469

9.74

307.65

1.4

1.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1774

4897

6.75

307.65

3.5

2.7

2.33

2.29

g/l

1.32

1686

4539

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1511

3302

7.66

307.65

7.8

2.6

13.82

7.98

umol/l

12.85

1413

2938

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

394

172

25.91

307.65

1.3

1.2

224.00

81.07

titre

2.08

(3032080) INR in Blood by Coagulation assay

2685

14448

5.84

307.65

26.1

16.2

1.31

1.28

inr

2.37

2377

12030

(3023487) Leukocytes [#/volume] in Peritoneal fluid

400

69.99

307.65

2.6

1.6

381.70

1155.78

e6/l

2.26

265

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

344

65.06

307.65

2.5

1.3

11453.10

5162.26

e6/l

0.46

171

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

422

373

12.85

307.65

1.1

1.0

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1757

2005

17.81

307.65

2.8

3.1

13.19

10.22

g/l

71.84

1665

1857

(3022948) Iron [Moles/volume] in Serum or Plasma

1819

5253

6.56

307.65

3.6

2.7

12.88

12.69

umol/l

0.44

1747

4910

(3006922) Hepatitis E virus Ab [Presence] in Serum

316

134

26.00

307.65

1.1

1.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

438

354

14.14

307.65

1.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2793

13738

8.16

307.65

14.5

5.0

33.00

35.45

g/l

87.73

2749

12872

(3020779) Urea [Moles/volume] in Serum or Plasma

1067

2998

4.80

307.65

12.7

7.4

11.24

10.21

mmol/l

3.78

1037

2874

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2856

15878

7.39

307.65

21.1

6.6

20.27

11.42

umol/l

54.05

2830

15161

(3002331) Protein [Mass/volume] in Peritoneal fluid

304

90.50

307.65

1.5

1.1

40.93

31.53

g/l

0.18

217

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

656

138

59.24

307.65

1.4

1.2

—

titre

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2074

2795

18.61

307.65

5.3

2.0

0.17

0.21

g/l

78.56

1929

2616

(3007566) Smooth muscle Ab [Titer] in Serum

1554

496

58.89

307.65

1.4

1.1

101.81

90.00

titre

0.31

149

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

546

116

56.32

307.65

1.1

1.0

294.71

292.24

mg/l

0.13

498

107

(3026692) Albumin [Mass/volume] in Peritoneal fluid

365

82.07

307.65

1.6

1.1

10.98

16.29

g/l

3.62

262

(40768441) Liver Pathology biopsy report

571

125

55.15

307.65

2.0

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1752

5304

5.97

307.65

1.9

1.5

3.94

2.41

g/l

82.99

1522

3120

(3033658) Prothrombin time (PT) actual/Normal

1848

7674

4.25

307.65

14.5

4.0

76.01

88.56

62.39

1798

7522

(3023183) Ammonium ion [Moles/volume] in Plasma

1142

531

32.54

307.65

5.7

1.6

44.13

30.54

umol/l

20.32

1099

462

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

546

675

9.51

307.65

1.4

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

762

1812

5.18

307.65

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

373

435

9.55

299.17

1.7

1.6

0.86

0.82

g/l

0.15

318

342

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

599

1179

6.00

298.39

3.6

3.5

115.56

3802.57

u/ml

0.96

527

1026

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1216

4258

3.96

293.51

9.0

6.2

1.09

1.04

mmol/l

5.85

1158

3952

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1950

9507

3.61

279.31

4.9

2.6

60.87

68.93

u/l

0.44

1863

8812

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1346

5320

3.60

266.34

5.4

3.5

0.78

0.82

mmol/l

28.82

1292

5004

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1726

8020

3.45

262.43

3.8

2.3

3.59

2.83

mg/l

19.21

1601

6914

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

290

292

10.80

258.50

1.3

1.1

46.22

66.87

u/l

3.31

269

258

(3042936) Bacteria identified in Isolate by Culture

1184

4421

3.63

253.94

3.2

2.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

192

20.97

251.85

4.1

1.9

0.58

0.62

mmol/l

4.10

192

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1245

4884

3.50

245.83

3.2

2.1

31.67

29.68

19.62

1207

4769

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

337

453

8.18

239.86

1.4

1.2

337.75

261.81

u/ml

2.54

190

270

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2276

12948

3.50

239.77

5.3

3.1

177.73

137.80

ug/l

6.46

2198

12025

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1048

3797

3.59

232.63

3.7

4.6

239.29

244.26

u/l

0.51

1017

3607

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

610

1506

4.75

231.20

2.1

1.8

1.08

1.56

g/l

28.58

529

1315

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1406

6124

3.28

231.11

1.5

1.3

1.88

1.51

u/ml

0.36

320

1650

(3027945) Reticulocytes/Erythrocytes in Blood

1037

3794

3.54

225.83

3.4

2.6

2.22

1.78

19.99

965

3393

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

345

522

7.27

220.81

1.5

1.4

—

(42870588) Differential panel, method unspecified - Blood

1914

10156

3.14

220.07

10.5

6.3

—

(3026250) Tacrolimus [Mass/volume] in Blood

181

108

17.68

219.61

43.0

37.4

6.98

7.23

ug/l

0.38

165

(40768797) Stomach Pathology biopsy report

1095

4223

3.40

218.15

1.4

1.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

362

586

6.82

217.38

8.3

5.7

938.08

657.80

iu/ml

0.35

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

338

521

7.12

212.47

1.4

25.94

22.10

u/ml

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

946

3381

3.53

212.07

3.8

4.4

6.23

22.26

ug/l

4.02

815

2772

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

432

859

5.64

209.92

2.2

1.7

—

(3019069) Monocytes/Leukocytes in Blood

2301

13805

3.26

208.51

11.8

6.7

9.59

8.99

15.24

2232

12894

(3001604) Monocytes [#/volume] in Blood

2423

14991

3.39

208.03

11.3

6.3

0.58

0.60

e9/l

1.31

2155

12745

(3006315) Basophils [#/volume] in Blood

2426

15042

3.39

207.05

11.3

6.3

0.04

e9/l

0.45

2159

12782

(3006504) Eosinophils/Leukocytes in Blood

2290

13779

3.22

204.84

11.7

6.6

3.08

2.85

5.03

2221

12865

(3022096) Basophils/Leukocytes in Blood

2289

13770

3.22

204.82

11.8

6.7

0.73

0.68

4.82

2222

12849

(3019198) Lymphocytes [#/volume] in Blood

2442

15294

3.37

202.85

11.4

6.4

1.67

1.90

e9/l

5.72

2199

13326

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

443

931

5.35

202.14

5.3

3.5

1.82

1.60

mg/l

4.85

422

847

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

430

883

5.46

201.36

4.1

2.5

2.86

3.65

g/l

20.50

424

847

(3018010) Neutrophils/Leukocytes in Blood

2279

13770

3.17

200.40

11.5

6.5

58.33

57.58

2.26

2226

13126

(3002030) Lymphocytes/Leukocytes in Blood

2309

14056

3.20

200.33

11.8

6.6

25.68

27.20

9.28

2252

13275

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

310

465

7.26

199.58

1.4

143.51

153.31

au/ml

0.45

144

(3042733) HLA Ab [Presence] in Serum

151

20.51

196.89

1.8

5.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

375

697

5.95

195.49

1.4

1.2

—

(3013115) Eosinophils [#/volume] in Blood

2446

15513

3.30

194.99

11.7

6.5

0.19

e9/l

0.42

2191

13405

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

207

193

11.38

193.85

1.1

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2450

15650

3.27

190.82

14.0

7.7

1.20

1.21

mmol/l

24.44

2200

13543

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2716

18462

3.81

190.46

12.2

3.2

157.97

48.34

u/l

147.82

2649

17202

(3021447) Carbon dioxide [Partial pressure] in Venous blood

895

3293

3.37

189.04

6.4

3.8

5.55

5.85

kpa

13.53

870

3206

(3023368) Bacteria identified in Blood by Culture

1680

8802

2.87

188.47

7.0

4.5

—

(3012544) pH of Venous blood

903

3353

3.34

187.75

6.4

3.8

7.38

0.43

547

1905

(3023520) Reticulocytes [#/volume] in Blood

833

2960

3.44

185.78

3.6

2.6

79.50

69.14

e9/l

8.31

621

2195

(3010375) cycloSPORINE [Mass/volume] in Blood

161

111

15.21

180.99

34.4

30.8

123.40

120.33

ug/l

0.16

136

(3002032) Base excess in Venous blood by calculation

868

3220

3.31

179.90

6.4

3.8

1.06

1.83

mmol/l

5.74

733

2815

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

809

2878

3.41

179.48

4.1

2.4

34.96

39.38

u/l

1.05

723

2450

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2263

14139

2.96

177.05

12.4

7.0

1.19

1.21

mmol/l

24.57

2185

13073

(3018418) pH of Serum or Plasma

1727

9394

2.78

176.78

6.6

4.4

7.40

2.60

1342

6801

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

184

168

11.55

174.57

1.5

1.1

137.97

77.74

u/l

5.62

170

142

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

181

162

11.77

173.99

1.5

1.1

32.46

20.54

u/l

1.35

166

135

(3020630) Protein [Mass/volume] in Serum or Plasma

774

2775

3.35

168.55

1.9

2.9

66.47

66.30

g/l

0.20

729

2556

(3013650) Neutrophils [#/volume] in Blood by Automated count

2517

16918

3.13

167.19

14.5

9.9

3.87

4.15

e9/l

6.54

2280

14579

(3000991) Gas panel - Venous blood

785

2853

3.31

167.02

13.9

9.3

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

612

1920

3.69

163.87

5.9

4.1

23.33

24.22

mmol/l

7.55

600

1902

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

346

711

5.32

160.85

3.2

3.5

1882.93

873.26

u/ml

0.24

316

652

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

143

15.06

160.25

1.7

1.4

1809232.11

1742174.83

iu/ml

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

275

473

6.26

154.50

2.8

2.9

662.50

1454.89

u/ml

0.44

(3024932) HLA-DR beta [Type]

124

17.86

152.06

1.0

1.2

—

(3024471) HLA-A [Type]

125

17.52

151.85

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

157

10.45

139.71

3.9

2.0

28.37

6.14

umol/l

8.84

143

102

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

161

173

9.74

135.97

1.8

1.5

8.54

6.29

u/l

0.59

135

141

(46235355) HIV 1 and 2 tests - Meaningful Use set

865

3691

2.83

135.44

1.9

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

1671

9774

2.45

135.27

4.4

2.5

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

747

2973

2.96

132.86

11.8

8.1

1.76

1.31

mmol/l

13.11

733

2924

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

348

840

4.52

132.69

3.4

2.5

225.50

200.40

4.47

339

803

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

183

247

7.79

128.67

1.2

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

618

2262

3.14

126.96

2.1

1.7

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

184

256

7.56

125.97

2.4

36.55

33.38

iu/ml

0.10

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

140

10.40

124.48

1.8

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

157

188

8.72

121.89

1.2

86.68

85.10

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

309

739

4.51

118.88

1.8

1.6

—

(3016502) Oxygen saturation in Arterial blood

799

3484

2.71

118.06

12.1

8.4

95.65

95.63

0.03

772

3375

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2899

22767

3.44

116.16

26.6

8.3

126.73

79.18

u/l

190.43

2869

21644

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

323

814

4.29

116.06

1.7

1.4

6.39

15.51

iu/ml

0.88

(3019977) pH of Arterial blood

854

3890

2.62

115.23

11.8

8.1

7.42

7.41

0.48

411

2147

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

377

1070

3.85

114.99

1.4

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1342

7513

2.34

114.82

4.2

2.4

—

(3001186) Copper [Moles/volume] in Serum or Plasma

16.73

114.29

1.3

1.2

17.51

15.70

umol/l

2.07

(3009445) Proteinase 3 Ab [Units/volume] in Serum

416

1271

3.61

113.76

1.6

10.97

21.94

iu/ml

0.73

(3036489) Thrombin time

385

1117

3.77

113.70

3.1

2.1

23.02

21.22

4.50

365

1010

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

852

3902

2.60

113.46

11.8

8.1

4.83

5.12

kpa

13.79

819

3763

(3027801) Oxygen [Partial pressure] in Arterial blood

852

3902

2.60

113.46

11.8

8.1

11.71

12.30

kpa

3.36

822

3762

(3003396) Base excess in Arterial blood by calculation

835

3866

2.56

108.05

11.9

8.0

-0.11

1.01

mmol/l

9.35

689

3212

(3002173) Hemoglobin [Mass/volume] in Arterial blood

740

3234

2.67

107.80

12.8

8.9

111.71

121.66

g/l

27.02

723

3170

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1985

13395

2.23

104.17

4.2

2.4

74.65

78.57

nmol/l

7.99

1884

12023

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

136

166

8.51

103.86

1.1

121.53

72.05

u/l

8.10

123

149

(3013826) Glucose [Moles/volume] in Serum or Plasma

2437

17927

2.42

103.53

12.0

5.3

7.52

6.75

mmol/l

36.59

2382

17145

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

14.47

102.54

1.6

1.4

11.17

8.22

ug/l

4.30

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1038

5417

2.34

102.23

2.4

1.9

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

101

12.38

101.40

1.1

1.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

134

167

8.32

100.59

1.1

36.10

21.57

u/l

2.69

121

149

(3023420) DNA double strand Ab [Units/volume] in Serum

374

1160

3.51

99.44

1.8

1.7

6.08

7.39

iu/ml

0.45

285

(3024354) Oxygen [Partial pressure] in Venous blood

639

2759

2.64

94.19

5.7

3.2

4.64

4.51

kpa

0.81

609

2679

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

350

1090

3.48

92.24

3.6

3.2

0.28

0.34

iu/ml

4.09

196

601

(3026493) Urate [Moles/volume] in Serum or Plasma

1351

8114

2.13

91.94

4.2

2.9

380.28

347.50

umol/l

18.55

1210

7125

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1998

13905

2.13

91.71

4.9

2.8

—

estimate

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

496

1908

2.89

91.26

13.9

10.8

14.75

16.04

17.25

482

1851

(3030467) Casts [#/volume] in Urine by Automated count

1417

8686

2.12

91.18

4.4

3.4

0.65

0.41

e6/l

2.92

1086

6422

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

513

2012

2.84

91.02

14.2

10.2

23.48

24.34

mmol/l

6.17

501

1978

(3002582) Erythrocytes [#/volume] in Urine

1578

10089

2.09

90.53

4.6

3.5

123.15

86.01

e6/l

0.22

1240

7743

(3026782) Osmolality of Urine

1069

5897

2.21

90.05

3.8

3.0

502.20

533.59

mosm/kgh2o

5.07

959

5181

(3019309) Folate [Moles/volume] in Red Blood Cells

988

5290

2.24

89.51

2.0

1.8

1198.66

1167.55

nmol/l

0.44

806

3988

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

372

1246

3.24

87.04

2.1

1.9

47.90

38.91

u/l

7.69

334

1101

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

469

1798

2.88

86.58

4.9

3.7

0.99

1.95

mmol/l

4.11

329

1328

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

939

4988

2.24

86.21

3.8

3.2

3.18

2.06

e6/l

1.64

498

2453

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

523

2144

2.71

84.85

5.1

3.8

4.86

5.17

kpa

11.56

505

2063

(3009343) pH of Capillary blood

512

2079

2.73

84.62

5.1

3.8

7.41

7.42

0.72

456

1728

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

809

4075

2.31

84.12

2.2

1.8

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

13.20

83.77

1.1

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

29.43

82.59

1.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1425

9047

2.02

80.46

2.2

1.7

18.54

20.37

nmol/l

5.17

1313

7584

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

342

1158

3.18

78.30

1.7

3.8

57.87

64.69

mg/l

0.19

290

990

(3018095) Leukocytes [#/volume] in Urine

1671

11301

1.98

77.90

5.6

4.1

96.56

100.83

e6/l

0.10

1270

8080

(3034860) Kappa light chains.free [Mass/volume] in Serum

341

1158

3.17

77.67

1.7

3.8

67.01

102.82

mg/l

0.35

289

989

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

754

3824

2.26

76.22

2.3

1.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

707

3506

2.30

75.31

2.1

1.8

—

(3017181) Myelocytes/Leukocytes in Blood

603

2793

2.42

75.11

5.9

4.5

0.70

0.94

2.15

261

878

(3002179) Metamyelocytes/Leukocytes in Blood

583

2665

2.45

74.74

5.7

4.3

0.80

0.70

0.23

248

827

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1509

9951

1.96

74.71

4.2

3.2

1977.29

1402.56

ng/l

3.17

1361

8636

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

313

1037

3.23

74.19

1.6

3.5

1.60

3.37

ratio

1.93

182

602

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

372

1369

2.94

73.47

1.6

2.5

4.42

4.18

g/l

4.03

344

1265

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

372

1369

2.94

73.47

1.6

2.5

7.09

7.37

g/l

2.43

345

1264

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

371

1369

2.93

72.90

1.6

2.5

4.28

3.68

g/l

8.80

345

1264

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

546

2458

2.47

72.19

5.4

4.0

96.02

92.69

ng/l

0.31

488

2116

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

301

991

3.24

72.04

1.4

1.3

—

(3021589) Normoblasts [#/volume] in Blood

1835

13030

1.93

71.76

24.3

12.0

0.00

e9/l

0.10

1536

10618

(3026008) Bacteria identified in Urine by Culture

1405

9140

1.94

71.48

4.1

3.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

957

5452

2.07

71.11

3.6

3.0

1.64

1.02

e6/l

0.84

519

2927

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

271

845

3.41

70.79

1.3

1.2

30.13

37.48

u/ml

0.23

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

234

671

3.68

69.46

1.3

1.2

18.86

4.60

u/ml

0.56

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1906

13801

1.92

69.18

2.8

2.2

94.59

95.39

pmol/l

0.29

1103

7284

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

328

1164

3.02

68.98

1.6

2.6

13.64

10.16

g/l

18.46

300

1049

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

259

804

3.41

68.08

1.3

1.2

5.70

6.80

u/ml

0.14

121

(3020191) Ethanol [Moles/volume] in Serum or Plasma

118

197

6.18

67.79

1.6

1.3

0.58

1.12

promille

3.41

103

151

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

258

803

3.40

67.52

1.3

1.2

26.30

3.37

u/ml

1.06

(3020682) Albumin/Creatinine [Ratio] in Urine

1580

10855

1.88

66.52

5.2

4.2

15.81

8.54

mg/mmol

4.57

1139

6792

(3028192) IgG subclass 2 [Mass/volume] in Serum

139

276

5.22

66.38

1.2

1.4

3.37

3.00

g/l

1.22

104

204

(3024139) IgG subclass 3 [Mass/volume] in Serum

139

276

5.22

66.38

1.2

1.4

0.73

0.40

g/l

2.66

104

204

(3027135) IgG subclass 1 [Mass/volume] in Serum

139

276

5.22

66.38

1.2

1.4

9.74

6.64

g/l

5.83

102

204

(3021440) Promyelocytes/Leukocytes in Blood

564

2673

2.34

66.00

6.1

4.5

0.05

0.13

3.35

224

760

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

267

869

3.26

64.97

1.5

1.6

1.17

1.19

g/l

0.45

254

830

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

262

843

3.29

64.96

1.5

1.6

0.21

0.24

g/l

6.88

247

806

(4062490) Immunoglobulin typing, IgG

137

274

5.18

64.89

1.2

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

1593

11031

1.87

64.86

4.5

3.4

6.86

7.51

mmol/l

8.29

1391

9286

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

341

1283

2.85

64.36

1.6

2.6

2.94

2.90

g/l

0.34

315

1178

(3025159) Blasts/Leukocytes in Blood

561

2697

2.30

63.29

6.2

4.7

0.34

0.22

0.15

207

715

(3039162) Centromere protein B Ab [Units/volume] in Serum

151

340

4.61

62.13

1.3

1.2

86.62

62.90

u/ml

0.49

(3036481) Cortisol [Moles/volume] in Serum or Plasma

566

2771

2.26

60.97

2.1

2.3

362.22

378.23

nmol/l

0.74

536

2564

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

224

687

3.43

59.88

1.6

1.7

—

(3012516) Albumin [Mass/volume] in Urine

1534

10687

1.82

59.50

4.2

3.5

87.77

47.28

mg/l

5.38

1125

6853

(3031040) Bacteria [#/volume] in Urine by Automated count

2383

19040

1.93

58.84

6.4

4.9

691.50

1914.58

e6/l

1.25

285

(4035726) Immunohistochemistry procedure

557

2748

2.24

58.71

1.7

1.4

—

(3000850) Epithelial cells [#/volume] in Urine

1111

7033

1.88

58.48

3.5

2.8

6.15

5.11

e6/l

1.54

1030

6424

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

313

1187

2.81

58.02

1.7

2.6

0.66

1.15

g/l

1.46

277

1023

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

444

1997

2.42

58.02

2.1

1.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

344

1376

2.68

57.49

2.3

1.9

2.06

2.16

ug/l

0.07

311

1232

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

205

612

3.51

57.12

1.3

1.2

65.74

46.85

u/ml

0.68

(36660697) Celiac disease serology panel - Serum

469

2179

2.35

56.88

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

272

966

2.98

56.84

1.6

2.5

0.01

0.00

g/l

0.50

238

849

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2606

21572

2.03

56.56

8.0

4.5

24.27

12.55

mm/h

136.87

2500

20141

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

278

1007

2.92

56.05

1.6

2.5

0.02

0.03

g/l

0.08

250

906

(3004119) Hemoglobin [Mass/volume] in Venous blood

451

2075

2.36

55.88

5.6

3.2

115.52

129.05

g/l

25.91

442

2013

(3037756) Immunofixation for Serum or Plasma

219

692

3.32

55.78

1.2

1.7

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1031

6455

1.87

55.61

2.4

1.8

2.20

1.31

mg/l

7.44

893

5088

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

256

893

3.03

55.19

1.6

2.5

0.00

g/l

-0.00

237

848

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

224

732

3.21

53.97

1.2

—

9.20

—

(3003181) Sodium [Moles/volume] in Urine

199

609

3.41

53.31

1.4

49.96

60.51

mmol/l

3.27

135

493

(3000093) Morphology [Interpretation] in Blood Narrative

133

308

4.46

52.80

1.2

1.1

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1007

6342

1.85

52.77

7.7

4.9

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

118

254

4.78

51.26

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

19.27

51.02

1.6

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

104

205

5.21

50.05

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

293

1160

2.68

49.77

3.5

3.1

23.46

24.86

mmol/l

5.39

287

1144

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

592

3182

2.05

49.28

4.5

3.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

120

273

4.53

48.71

2.0

1.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

106

218

4.99

48.59

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

185

573

3.36

48.58

1.6

1.7

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

180

551

3.40

48.16

1.2

1.3

106.00

463.48

titre

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

105

216

4.99

48.12

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

105

216

4.99

48.12

1.1

—

(3021901) Oxygen saturation in Capillary blood

201

663

3.16

47.61

3.4

3.2

89.57

89.49

0.05

195

646

(3018333) Ribosomal P Ab [Presence] in Serum

100

199

5.15

47.61

1.1

—

(3022313) Gas panel - Capillary blood

340

1481

2.45

47.26

5.6

3.9

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

106

226

4.81

46.57

1.1

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

148

407

3.76

46.55

1.2

1.1

22.17

9.82

u/ml

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

101

209

4.95

45.97

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

335

1469

2.43

45.84

6.1

3.2

24.35

25.30

mmol/l

3.76

320

1415

(3022145) Colonoscopy Study observation

620

3477

1.97

45.44

1.7

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

269

1069

2.65

45.25

1.3

1.2

0.40

1.24

u/ml

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

183

591

3.22

44.88

1.5

1.7

0.95

0.83

nmol/l

1.36

152

498

(3003434) Protein [Mass/volume] in Pleural fluid

159

475

3.47

44.17

1.7

1.5

27.76

32.70

g/l

4.34

142

428

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

282

1161

2.56

44.11

2.5

2.3

1168.40

684.19

ug/l

0.67

263

1107

(3000012) Reticulocyte production index

160

481

3.45

44.01

3.0

2.2

1.04

0.89

1.67

126

332

(3024928) Oxygen saturation in Venous blood

225

838

2.81

42.89

4.5

3.2

60.67

61.54

0.20

208

819

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

940

6112

1.76

42.53

4.9

4.1

405.07

565.67

ng/l

0.40

789

4997

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

204

725

2.93

42.39

1.5

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

347

1600

2.31

42.23

1.6

1.5

—

(3000494) Fungus identified in Specimen by Culture

640

3716

1.90

41.94

2.0

1.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

153

464

3.41

41.51

7.2

6.5

12.78

12.19

mg/l

0.74

138

437

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

321

1468

2.32

39.75

6.5

5.2

1.77

1.58

3.28

302

1398

(40758558) Short blood count panel - Blood

1278

9169

1.65

39.33

10.3

6.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

963

6425

1.71

39.10

2.0

1.7

31752328.92

31450524.91

pmol/l

0.00

822

5310

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

479

2579

2.00

38.98

3.3

2.8

56.31

64.87

ml/min/173m2

3.45

220

1108

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

268

1142

2.47

38.87

5.8

3.9

23.81

24.90

mmol/l

5.43

252

1062

(3012441) Differential panel - Pleural fluid

129

366

3.63

38.75

1.7

1.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

463

2482

2.01

38.09

5.6

4.2

1.21

1.23

mmol/l

6.08

441

2154

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

474

2575

1.98

37.51

4.1

3.1

257.97

200.58

ng/l

1.93

441

2371

(1616796) Gas panel - Central venous blood

190

706

2.80

36.31

4.5

4.2

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1330

9792

1.60

35.90

2.7

2.2

241.31

224.50

u/l

0.24

1276

9267

(3007930) Methemoglobin/Hemoglobin.total in Blood

293

1345

2.29

35.86

6.7

5.4

0.85

0.87

0.42

276

1279

(3048689) Calprotectin [Mass/mass] in Stool

580

3415

1.85

35.83

3.1

2.3

170.48

141.95

ug/g

1.23

504

2726

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

263

1165

2.37

34.93

2.7

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

199

774

2.67

34.81

2.2

2.0

13.12

12.21

mg/l

0.59

190

716

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

14.04

34.80

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

177

4.67

34.57

2.5

1.8

—

(3004809) Band form neutrophils/Leukocytes in Blood

156

535

3.01

34.50

3.4

3.6

1.46

1.58

0.15

141

477

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

333

1645

2.14

33.96

7.3

3.8

46.46

47.47

0.30

327

1613

(3023199) Leukocytes [#/volume] in Pleural fluid

135

435

3.19

33.21

1.7

1.4

1425.98

3734.57

e6/l

0.61

309

(3015736) pH of Urine

1589

12345

1.56

33.09

4.3

3.5

6.24

6.23

0.11

816

6871

(40768806) Pleura Pathology biopsy report

120

361

3.41

32.97

1.7

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

156

4.76

32.02

1.7

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

156

4.76

32.02

1.7

1.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

122

379

3.31

31.86

1.7

1.4

17725.00

90600.30

e6/l

2.33

216

(3035350) Ketones [Presence] in Urine by Test strip

1915

15591

1.55

31.74

5.1

4.0

11.13

3.75

estimate

0.71

488

3335

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

211

887

2.47

31.41

1.6

1.3

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

385

2065

1.98

31.29

9.5

6.8

23.56

24.55

mmol/l

4.30

368

1985

(3014051) Protein [Presence] in Urine by Test strip

1114

8057

1.58

31.29

3.6

3.0

0.06

0.03

0.23

210

(3021601) Nitrite [Presence] in Urine by Test strip

1892

15409

1.54

30.94

5.1

4.0

0.00

estimate

0.80

476

3255

(3009261) Glucose [Presence] in Urine by Test strip

1919

15699

1.54

30.57

5.2

4.1

4.75

0.11

estimate

0.78

424

3104

(3045788) Cell count panel - Pleural fluid

114

354

3.30

29.80

1.8

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

200

849

2.44

29.14

1.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1401

10791

1.52

29.00

3.9

3.6

2.33

2.36

mmol/l

8.70

1295

9794

(3022493) Free Hemoglobin [Mass/volume] in Plasma

137

4.82

29.00

1.5

6.3

184.49

73.98

mg/l

0.44

103

(37208534) Antinuclear antibody arbitrary concentration in serum

6.10

28.90

1.0

—

(21494434) Karyotype in Bone marrow

103

306

3.44

28.88

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

185

4.18

28.33

1.4

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

211

931

2.35

28.19

1.4

1.5

283.54

274.98

ug/g

0.20

122

564

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

6.74

28.04

1.1

—

(3017732) Neutrophils [#/volume] in Blood

597

3784

1.71

27.99

3.7

3.4

4.88

4.67

e9/l

0.17

528

3246

(3052851) Hemolysis interference index of Serum or Plasma

196

840

2.42

27.96

4.9

3.4

2.01

2.18

index

0.15

107

419

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

182

4.14

27.22

1.4

1.3

—

(3037121) Protein [Mass/volume] in Urine

229

1062

2.24

27.22

3.2

3.4

498.43

405.42

mg/l

0.19

138

458

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

5.43

27.12

1.2

1.7

87.44

143.70

umol/l

0.64

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

106

338

3.21

26.56

1.3

1.78

1.48

nmol/l

1.33

305

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1501

11886

1.49

26.29

5.7

4.0

81.61

101.55

ng/l

0.16

1221

8821

(3027923) C peptide [Moles/volume] in Serum or Plasma

167

4.20

25.93

1.4

1.26

1.08

nmol/l

0.80

121

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

261

3.48

25.48

1.4

1.3

9.81

12.05

u/l

1.08

237

(3008757) Leukocyte morphology finding [Identifier] in Blood

100

316

3.23

25.44

3.4

4.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

175

749

2.41

25.03

3.0

2.3

116.61

129.51

g/l

7.48

142

576

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

193

868

2.30

24.66

1.6

—

(3020876) Protein [Mass/time] in 24 hour Urine

114

397

2.94

24.57

1.7

2.4

1.09

1.29

g/24h

0.36

230

(3047181) Lactate [Moles/volume] in Blood

205

953

2.23

24.20

7.2

6.2

1.76

1.34

mmol/l

2.35

176

853

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

107

4.92

23.89

3.1

2.0

44578.90

3487.72

u/ml

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

136

4.40

23.63

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

294

3.19

23.00

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

190

883

2.22

22.44

1.6

1.5

0.25

9.43

iu/ml

0.65

161

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

167

735

2.34

22.43

2.4

2.3

102.30

99.08

ug/min

0.04

456

(3012501) Base excess in Blood by calculation

152

642

2.43

22.39

5.4

4.7

2.38

2.62

mmol/l

0.38

445

(3017354) Segmented neutrophils/Leukocytes in Blood

100

344

2.97

22.05

3.1

3.6

60.33

57.43

0.65

293

(21494890) Protein electrophoresis panel - 24 hour Urine

100

345

2.96

21.94

1.4

2.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

133

4.27

21.61

1.4

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

133

4.27

21.61

1.4

1.3

—

(3042631) Mycobacterium sp identified in Specimen

113

424

2.72

21.23

2.5

2.7

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

135

4.20

21.20

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

207

1021

2.10

21.02

1.7

1.6

31.27

19.28

u/ml

1.20

214

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

143

608

2.41

20.77

1.6

1.7

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

30.23

20.54

3.1

2.8

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

963

7244

1.47

20.52

4.3

3.9

0.00

0.12

1.94

(3018405) Lactate [Moles/volume] in Arterial blood

217

1100

2.04

20.47

5.6

3.7

1.92

1.32

mmol/l

5.15

212

1083

(4198724) Urine methamphetamine measurement

5.96

20.41

7.6

1.7

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

141

604

2.39

20.15

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

141

604

2.39

20.15

1.5

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

114

442

2.64

20.10

1.1

148.48

70.89

iu/ml

0.29

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

217

1114

2.02

19.77

2.2

1.8

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

138

591

2.39

19.73

1.1

1.3

200.06

202.45

miu/ml

0.02

243

(3004616) Nuclear Ab [Presence] in Serum

362

2.79

19.56

1.4

1.2

—

(3038026) Centromere Ab [Units/volume] in Serum

229

3.28

19.54

1.2

69.81

57.13

u/ml

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

231

1218

1.96

19.50

2.4

1.9

—

(3016038) Potassium [Moles/volume] in Urine

218

3.31

18.99

1.1

1.2

35.86

34.58

mmol/l

0.16

189

(3019230) Fractional oxyhemoglobin in Venous blood

159

737

2.22

18.91

5.2

2.9

58.53

62.14

1.15

159

732

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

369

2.74

18.87

1.4

—

(3008838) Granulocytes/Leukocytes in Peritoneal fluid

+∞

18.76

1.8

0.0

28.20

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

371

2.72

18.68

1.4

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

310

2.89

18.64

1.2

1.1

75.00

35.50

u/ml

0.97

(3044927) Protein electrophoresis panel - Urine

322

2.85

18.53

1.2

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

102

391

2.66

18.42

1.5

1.4

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

7.48

18.23

1.7

1.3

—

(3035880) pH of Pleural fluid

189

3.43

18.21

1.4

1.3

7.41

7.40

0.12

132

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

107

428

2.55

17.74

1.6

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

141

3.80

17.60

2.4

2.5

1851.55

1120.67

u/ml

0.60

141

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

109

443

2.51

17.48

1.6

—

(3019225) pH of Specimen

457

3023

1.60

17.46

6.8

4.4

7.38

7.36

2.83

392

2145

(3025468) Yersinia sp identified in Specimen by Organism specific culture

368

2.66

17.35

1.5

1.4

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

4.39

17.31

1.6

1.5

2.15

2.92

0.31

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

386

2.61

17.30

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

388

2.60

17.12

1.5

1.4

—

(3009871) Measles virus Ab [Titer] in Serum

108

4.12

16.32

1.7

1.6

5165.71

3360.00

titre

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

263

2.90

16.06

1.2

1.1

42.83

78.00

u/ml

—

(3025941) Bacteria identified in Stool by Culture

250

1443

1.79

15.91

1.3

—

(3008295) Osmolality of Serum or Plasma

344

2.60

15.33

1.3

1.4

278.29

275.97

mosm/kgh2o

0.37

256

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

5.91

15.24

1.6

22.54

7.95

1.38

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

126

2529

0.48

15.11

1.8

2.1

3.50

ratio

0.02

105

2033

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

6.53

14.92

1.1

1.2

14.68

25.91

u/l

1.29

(44790047) Parainfluenza type 1 nucleic acid detection

100

422

2.41

14.84

1.6

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

100

422

2.41

14.84

1.6

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

100

422

2.41

14.84

1.6

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

100

422

2.41

14.84

1.6

1.4

—

(3035933) Granulocytes/Leukocytes in Blood

130

614

2.16

14.81

4.3

3.2

56.09

58.06

0.94

130

614

(3030981) Hyaline casts [#/volume] in Urine by Automated count

398

2649

1.57

14.69

3.1

2.5

0.87

0.44

e6/l

1.01

386

2537

(3005532) Lymphocytes/Leukocytes in Pleural fluid

122

3.73

14.59

1.6

1.5

62.51

63.72

0.08

100

(1761868) Lipid panel - Serum or Plasma

812

10315

0.72

14.56

4.3

3.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

5.22

14.37

1.1

1450.00

811.76

titre

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

5.99

14.31

2.2

3.1

45.84

22.54

mg/l

—

(3018572) Chloride [Moles/volume] in Blood

135

661

2.09

14.03

8.9

7.2

104.80

105.25

mmol/l

0.47

121

603

(3039000) Anion gap in Blood by calculation

135

661

2.09

14.03

8.9

7.2

11.57

11.40

mmol/l

0.18

121

603

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

289

2.67

14.02

3.4

2.7

—

(40768804) Tissue Pathology biopsy report

1404

11801

1.33

13.97

2.6

2.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

821

6359

1.39

13.87

3.2

3.1

2.50

2.46

mmol/l

16.08

728

5730

(3003694) ABO and Rh group [Type] in Blood

998

7978

1.36

13.85

1.6

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

146

741

2.02

13.77

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

299

2.61

13.63

4.5

3.5

15.08

11.29

index

1.49

168

(3027456) Digoxin [Moles/volume] in Serum or Plasma

133

663

2.05

13.19

3.6

3.4

0.80

0.81

nmol/l

0.15

540

(21494755) Public health laboratory ask at order entry panel

1926

0.45

12.86

1.3

1.4

—

(40768443) Skin Pathology biopsy report

229

1371

1.72

12.83

1.2

—

(3045142) Bone marrow Pathology biopsy report

400

2.34

12.82

1.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

14.08

12.74

1.3

1.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

359

2.40

12.64

10.2

5.3

8.58

7.28

mmol/l

1.99

298

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1805

0.44

12.62

1.7

1.8

3.34

3.47

mmol/l

0.44

1302

(3028707) Methadone [Presence] in Urine by Screen method

232

2.75

12.40

6.3

2.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.92

12.26

1.3

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

993

8052

1.34

12.22

4.7

3.5

1.33

0.13

estimate

0.70

379

2533

(3002256) Pathology report gross observation

557

4114

1.43

12.21

1.4

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

127

641

2.02

12.19

1.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2924

27725

1.52

11.99

43.4

17.1

20.68

25.36

mg/l

22.03

2806

23039

(3027974) Hepatitis B virus e Ag [Presence] in Serum

14.69

11.77

1.3

1.7

—

(3017569) Oxygen content in Arterial blood

194

2.87

11.74

2.3

14.64

16.19

2.39

194

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

124

638

1.98

11.31

1.5

—

(3004775) Volume in Urine collected for unspecified duration

242

2.59

10.93

2.2

2.3

737.41

634.21

0.77

162

(40761536) Microorganisms panel - Urine sediment

335

2291

1.52

10.84

5.1

4.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

108

540

2.03

10.68

1.4

1.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

394

2793

1.47

10.68

2.6

2.4

10.84

7.59

ug/l

0.95

349

2489

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

254

2.51

10.41

1.4

1.5

28.77

26.30

u/ml

0.15

(40768446) Kidney Pathology biopsy report

116

3.30

10.39

1.4

1.6

—

(3044242) Glucose [Moles/volume] in Arterial blood

197

2.72

10.31

1.8

2.2

8.82

8.50

mmol/l

0.19

197

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

143

3.03

10.22

2.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

123

657

1.91

10.09

1.0

1.1

3.90

4.45

eliau/ml

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

114

594

1.95

10.06

1.2

1.3

44.17

39.75

u/l

0.16

105

510

(3043409) Potassium [Moles/volume] in Arterial blood

157

917

1.75

9.65

6.7

4.0

3.95

3.89

mmol/l

0.60

157

909

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

285

2.34

9.44

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

243

2.45

9.36

1.3

1.2

—

(3017704) Immunofixation for Urine

181

2.68

9.12

1.3

1.6

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

4.59

9.05

1.1

1.3

66.00

74.36

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

4.59

9.05

1.1

1.3

79.90

79.91

—

(3011412) CD3 cells [#/volume] in Blood

288

2.28

8.79

1.9

2.4

822.54

1142.27

e6/l

3.04

259

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

221

2.47

8.71

2.3

2.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

329

2.18

8.63

1.5

1.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

351

2.13

8.49

1.5

1.6

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

100

3.22

8.48

1.3

1.2

9.39

401.37

ug/l

0.70

(3004347) Hepatitis D virus Ab [Presence] in Serum

20.07

8.46

1.0

—

(3029937) Albumin [Presence] in Urine by Test strip

1035

8768

1.26

8.45

5.4

4.2

0.00

estimate

1.34

414

2987

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

749

9072

0.77

8.45

3.6

4.6

23.03

21.89

0.86

306

4609

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

12.78

8.36

3.9

1.5

268.86

164.82

ug/g

0.65

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

4.89

8.35

1.7

1.5

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

4.89

8.35

1.1

1.9

2.54

1.19

mmol/l

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

118

662

1.81

8.35

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

421

2.02

8.33

1.5

1.2

3.53

5.47

u/ml

0.69

186

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

433

1.99

8.07

1.4

1.2

2.63

3.28

u/ml

0.31

152

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

535

6742

0.75

8.07

2.7

3.3

0.73

0.78

ug/l

0.64

355

4563

(3032057) Clostridioides difficile [Presence] in Stool

3.77

8.06

2.0

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

280

2.24

8.04

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

280

2.24

8.04

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

280

2.24

8.04

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

123

708

1.77

8.00

6.0

4.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

269

2.25

7.92

1.5

1.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1740

15690

1.23

7.90

3.0

2.6

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

3.71

7.89

1.3

0.38

0.29

mmol/l

—

(3043410) Blood group antigens tested for on Red Blood Cells

3.31

7.79

2.4

1.8

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.52

7.64

1.1

1.3

0.17

1.00

u/ml

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

157

2.63

7.61

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

157

2.63

7.61

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

157

2.63

7.61

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

157

2.63

7.61

1.6

—

(3047189) Immunofixation for 24 hour Urine

164

2.58

7.51

1.1

1.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

326

2.08

7.25

1.1

—

(3018291) Platelet Ab [Presence] in Serum

15.77

7.22

1.2

1.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1315

11593

1.22

7.17

5.4

4.0

0.52

0.27

estimate

0.26

392

2667

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

3.45

7.11

3.2

8.4

57.54

72.94

0.90

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

229

1581

1.48

7.09

2.5

2.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.06

7.07

12.3

15.1

4.68

5.26

mmol/l

0.81

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

4.06

7.07

2.0

2.2

—

(3014271) Vancomycin [Susceptibility]

153

2.57

6.93

3.8

2.9

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

125

756

1.68

6.86

1.2

1.1

—

(3016750) Collection duration of Urine

184

2.41

6.85

2.3

2.1

498.32

494.09

min

0.08

137

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

154

2.55

6.84

2.8

3.5

1.10

1.26

0.21

154

(3006653) Thiamine [Moles/volume] in Blood

172

2.46

6.84

1.3

1.2

127.83

134.76

nmol/l

0.52

172

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

3.26

6.82

1.2

79.39

88.67

0.90

(3011288) Drugs identified in Urine by Screen method Nominal

384

1.95

6.73

8.9

2.3

—

(3000330) Specific gravity of Urine by Test strip

221

1532

1.47

6.72

5.0

3.4

1.02

ratio

0.35

205

1396

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.89

6.70

2.0

2.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

125

763

1.66

6.64

1.2

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

422

1.89

6.60

6.2

1.7

—

(4146454) Self-monitoring of blood glucose

355

1.96

6.45

3.1

2.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

165

2.44

6.43

2.5

2.2

20.66

27.98

umol/l

—

(3045424) Erythrocytes [Presence] in Urine

220

1539

1.46

6.40

2.5

2.2

0.00

0.55

estimate

0.51

466

(42529406) Shigella sp [Presence] in Stool by Culture

125

772

1.64

6.36

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

114

2.74

6.27

1.5

1.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

204

1412

1.47

6.27

2.6

3.8

170.78

77.83

u/ml

2.11

193

1358

(3026389) Candida sp identified in Specimen by Organism specific culture

374

1.92

6.21

1.6

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

3.13

6.16

1.2

1.5

76.06

90.90

1.12

(3045414) Leukocytes [Presence] in Urine

385

2995

1.32

5.92

2.6

2.2

0.00

0.01

estimate

0.78

599

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

351

1.90

5.64

4.5

3.9

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

121

2.58

5.62

1.0

1633.97

1560.47

miu/ml

0.16

121

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.89

5.61

1.6

1.5

0.33

0.37

ug/l

0.25

(4195642) Thrombophilia screening test

382

1.85

5.54

1.3

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1112

0.54

5.50

1.5

1.8

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

712

0.43

5.48

1.2

1.1

0.69

0.63

ratio

—

105

(3039443) Prostate specific Ag panel - Serum or Plasma

640

0.40

5.44

1.2

1.7

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

7.08

5.43

1.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

143

2.39

5.30

1.5

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

188

2.20

5.25

1.7

2.5

400.66

542.47

e6/l

0.98

156

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

774

0.47

5.12

1.3

1.2

1.55

1.54

g/l

0.17

774

(4268621) Lupus anticoagulant assay

302

1.90

4.97

2.6

2.2

—

(3016879) Cocaine [Presence] in Urine

516

1.68

4.97

6.0

1.8

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

5.43

4.91

1.1

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

413

1.76

4.88

1.5

1.3

—

(3027008) Opiates [Presence] in Urine

559

1.65

4.82

3.5

1.8

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

156

2.26

4.82

3.7

4.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.83

4.81

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

119

2.45

4.79

1.8

1.7

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

2.89

4.76

1.5

1.2

1.33

1.80

mmol/l

1.48

(3028433) Virus identified in Specimen by Culture

2.68

4.74

1.3

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

562

1.64

4.72

5.8

1.8

—

(3028300) Cannabinoids [Presence] in Urine

562

1.64

4.72

6.2

1.8

—

(3010838) Calcium [Moles/time] in 24 hour Urine

565

1.63

4.63

1.7

2.0

4.61

4.87

mmol/24h

0.29

491

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.59

4.63

4.0

2.8

4.51

4.97

kpa

1.69

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.59

4.63

4.0

2.8

9.73

10.23

kpa

0.47

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

159

2.21

4.62

1.3

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

3.34

4.60

1.8

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.91

4.60

1.3

1.8

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

4.53

4.55

1.1

1.0

—

(44786800) Granulocytes/Leukocytes in Body fluid

4.53

4.55

1.2

1.4

16.60

17.75

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

283

1.89

4.55

1.7

1.5

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

228

1.99

4.50

1.4

1.6

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.54

4.46

1.2

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.77

4.44

7.0

7.8

6.06

5.35

kpa

0.62

(3042010) Triglyceride [Moles/volume] in Pleural fluid

2.89

4.33

1.5

1.3

0.32

1.68

mmol/l

1.48

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

391

1.73

4.32

1.0

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

128

875

1.48

4.28

1.4

—

(3027944) Amphetamines [Presence] in Urine

554

1.60

4.27

5.1

1.7

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

127

2.29

4.19

1.2

1.1

211.99

190.87

iu/ml

0.14

127

(3004716) Salmonella sp identified in Stool by Organism specific culture

162

1164

1.41

4.17

1.4

1.3

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2391

22812

1.18

4.17

54.0

21.2

14.93

13.70

182.43

2384

22483

(3023419) Bacteria identified in Sputum by Culture

442

1.67

4.13

4.6

2.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

243

1.91

4.11

2.1

2.0

1.21

1.53

u/field

0.36

129

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

384

1.71

4.04

2.0

1.8

4409.39

4168.95

u/l

0.02

142

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

117

2.32

4.01

1.8

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

117

2.32

4.01

1.8

1.7

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.94

4.00

1.9

1.7

—

(3026361) Erythrocytes [#/volume] in Blood

2934

29986

0.79

3.97

64.4

26.1

4.13

4.47

e12/l

152.83

2881

29262

(3035941) MCH [Entitic mass]

2934

29983

0.79

3.93

64.2

26.0

30.66

30.41

7.44

2915

29645

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

184

2.02

3.93

3.2

2.8

35.03

40.43

1.10

(3029634) Reagin Ab [Titer] in Serum by VDRL

358

1.72

3.89

1.9

2.1

—

8.67

—

(3010813) Leukocytes [#/volume] in Blood

2935

29986

0.79

3.86

64.5

26.2

6.60

6.76

e9/l

2.00

2885

29261

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2935

29985

0.79

3.85

66.5

26.7

37.31

40.30

139.72

2916

29634

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2935

29983

0.79

3.83

64.3

26.1

92.62

91.44

25.36

2916

29646

(3000963) Hemoglobin [Mass/volume] in Blood

2936

29991

0.79

3.81

65.2

26.3

123.85

135.03

g/l

196.25

2920

29659

(3007461) Platelets [#/volume] in Blood

2935

29981

0.79

3.80

64.6

26.2

199.42

247.57

e9/l

163.75

2891

29362

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

612

5278

1.20

3.79

1.4

1.3

41.99

34.31

iu/ml

0.61

206

1627

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

8.77

3.77

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

8.77

3.77

1.0

0.08

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

409

1.65

3.71

1.2

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2283

21788

1.16

3.63

4.7

4.4

14.87

14.89

pmol/l

0.12

2123

19886

(3006571) Granulocytes/Leukocytes in Synovial fluid

361

1.67

3.53

1.3

1.6

71.34

60.01

1.39

223

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

431

1.61

3.51

1.9

1.5

—

(21494814) CD8 cells/Lymphocytes in Specimen

131

2.15

3.51

2.0

26.32

30.39

0.93

131

(3008402) Methanol [Moles/volume] in Serum or Plasma

3.88

3.48

1.0

1.2

—

mmol/l

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.88

3.48

1.2

1.4

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

3.88

3.48

1.0

1.2

—

mmol/l

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.42

3.30

1.6

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

204

1.87

3.30

1.5

1.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

212

1.85

3.26

1.5

1.6

—

(3025130) Human papilloma virus identified in Specimen

294

1.71

3.23

2.2

1.9

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

242

1.79

3.22

1.9

1.2

91.19

104.96

pmol/l

1.14

242

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

242

1.79

3.22

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

227

1797

1.28

3.14

1.3

207.69

223.16

u/ml

0.17

211

1659

(3000034) Microalbumin [Mass/volume] in Urine

267

1.73

3.12

4.8

3.0

60.48

39.28

mg/l

0.36

196

(3020123) Porphyrins [Interpretation] in Serum or Plasma

4.51

3.11

1.2

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

5.01

3.05

4.0

11.9

—

(3042517) Benzodiazepines panel - Urine

5.84

3.02

4.0

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

247

1990

1.26

2.98

1.2

1.3

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

10.01

2.98

4.2

10.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.47

2.95

1.5

1.1

440.78

254.76

pmol/l

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

141

1.99

2.95

1.4

1.7

37.51

40.02

g/l

1.36

141

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

4.71

2.92

1.9

3.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

193

1.82

2.84

1.6

94.14

84.98

umol/l

0.80

193

(4015189) Microbial culture of sputum

2.30

2.84

3.1

2.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

401

1.56

2.80

1.2

1.4

340.64

310.10

pmol/l

0.21

339

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

2.23

2.80

1.3

1.1

12.89

9.84

pmol/l

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

194

1.81

2.79

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

173

1.86

2.76

1.0

1.1

—

(40768800) Prostate Pathology biopsy report

777

0.63

2.76

1.2

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

8.34

2.75

3.8

5.3

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

8.34

2.75

1.2

1.0

243.40

291.67

u/ml

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

8.34

2.75

1.0

—

mmol/l

—

(3003327) Ova and parasites identified in Stool by Light microscopy

127

946

1.36

2.75

1.5

1.7

—

(3000060) B lymphocytes [#/volume] in Blood

2.37

2.72

2.0

2.9

0.16

0.18

e9/l

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

6.01

2.70

1.0

1.4

—

(40768793) Breast Pathology biopsy report

710

0.61

2.68

1.4

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

111

813

1.38

2.67

1.5

1.7

16332.63

13117.56

e6/l

0.34

563

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

199

0.35

2.66

1.0

1.5

203.13

211.92

pmol/l

—

199

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

296

1.63

2.65

1.4

1.5

—

(3022621) pH of Urine by Test strip

280

2321

1.23

2.64

3.2

2.8

5.97

6.06

1.14

206

1585

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

198

1.78

2.63

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.39

2.63

1.4

—

(3049717) Cytology report of Urine Cyto stain

164

1277

1.30

2.63

2.7

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

650

1.41

2.55

1.5

1.4

12.01

10.07

u/l

0.44

522

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

584

1.43

2.53

1.4

1.5

127.73

231.57

pmol/l

1.80

569

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.23

2.51

1.1

1.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2683

27484

0.87

2.50

6.6

5.3

1.34

1.45

mmol/l

31.73

2533

25416

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1040

11245

0.89

2.50

4.5

5.7

1.99

3.26

ug/l

1.94

923

10180

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.98

2.48

1.5

1.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2662

25906

1.15

2.47

6.1

5.4

2.19

1.95

mu/l

10.73

2517

23786

(3036525) Urea [Moles/time] in 24 hour Urine

4.38

2.47

3.7

3.9

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.38

2.47

4.7

3.9

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

283

2367

1.21

2.46

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

2.46

2.44

7.3

7.4

11.09

10.34

0.53

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

2.90

2.41

1.0

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

209

1699

1.25

2.38

2.7

3.5

4.08

4.44

pmol/l

4.98

187

1509

(3011985) Renin [Units/volume] in Plasma

434

1.48

2.37

1.5

1.4

139.13

64.76

mu/l

0.64

384

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.64

2.36

1.0

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

133

1.89

2.31

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

4.62

2.27

1.0

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

555

4944

1.15

2.27

1.4

1.3

13.36

13.13

u/ml

0.02

192

1896

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

156

0.32

2.27

1.0

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2705

27647

0.87

2.20

6.8

5.4

4.21

4.58

mmol/l

58.69

2572

25735

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

448

3939

1.16

2.20

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2754

28108

0.87

2.16

7.4

6.2

2.36

2.65

mmol/l

57.42

2608

26069

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

100

751

1.34

2.12

1.3

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

3.21

2.09

2.3

2.8

0.75

0.60

ug/l

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

2.26

2.07

1.1

1.4

—

127.33

—

(44806071) Cardiolipin IgM antibody measurement

2.91

2.07

1.3

1.1

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

253

1.59

2.06

1.5

1.8

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

224

2672

0.83

2.05

2.2

2.3

13.41

13.32

nmol/l

0.05

201

2396

(3019832) Treponema pallidum Ab [Presence] in Serum

170

1377

1.25

2.04

1.7

1.6

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

4.00

2.04

7.7

10.5

103.50

104.07

g/l

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.41

2.02

1.2

1.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

162

1.73

2.02

2.3

2.1

230.29

172.86

ug/min

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.64

2.00

2.0

1.8

—

(3004451) EKG impression Narrative

201

1.65

1.98

1.4

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

207

1726

1.21

1.91

1.2

127.88

145.28

u/ml

0.26

617

(3022689) Creatine [Moles/volume] in Urine

1.92

1.90

2.1

1.5

8.22

7.98

mmol/l

0.09

(40765096) Chromosome analysis panel by Banding

121

1.82

1.88

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.65

1.86

1.0

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2931

28834

1.16

1.86

51.6

20.6

138.35

139.73

mmol/l

105.94

2908

28313

(3036670) Protein [Mass/volume] in Synovial fluid

1.92

1.80

1.2

1.3

33.48

39.10

g/l

—

(3002079) Sodium [Moles/time] in 24 hour Urine

131

1.76

1.77

1.2

1.3

130.09

166.40

mmol/24h

1.31

131

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

2.09

1.76

1.1

1.3

—

(37021550) Renin [Units/volume] in Plasma --upright

2.09

1.76

1.3

1.4

96.02

46.12

mu/l

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

3.34

1.74

1.2

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.50

1.74

1.1

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

170

1.65

1.73

1.2

1.1

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

290

1.49

1.72

1.5

21.19

30.08

0.81

180

(3004446) Plasmodium sp identified in Blood by Light microscopy

3.16

1.66

2.5

2.4

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.58

1.66

1.0

1.9

—

(3002619) Bacteria identified in Specimen by Culture

2.03

1.64

1.6

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

705

1.30

1.62

1.2

1.1

2.65

4.23

—

(3020491) Glucose [Moles/volume] in Blood

205

1.57

1.62

2.1

1.9

7.79

6.89

mmol/l

0.74

130

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

328

1.44

1.60

1.0

1.1

4.27

2.65

eliau/ml

0.32

135

(3034426) Prothrombin time (PT)

1.87

1.60

1.6

1.2

28.88

29.27

0.16

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.07

1.59

1.0

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2931

28888

1.14

1.54

51.9

20.8

4.00

3.99

mmol/l

1.27

2909

28314

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1186

12495

0.92

1.52

2.4

2.0

1.41

1.36

mmol/l

1.25

1046

10411

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.60

1.51

2.3

2.7

0.86

0.59

u/field

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

903

0.76

1.48

2.2

1.7

5.72

4.77

mg/l

0.43

677

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

2.00

1.48

1.0

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

124

1.70

1.47

1.0

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

170

0.47

1.46

1.4

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

179

1.57

1.45

2.1

1.8

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

369

1.39

1.45

1.1

3.75

3.66

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

102

1.77

1.44

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

102

1.77

1.44

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

102

1.77

1.44

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

102

1.77

1.44

1.1

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.97

1.43

1.2

1.4

1.16

1.18

mmol/l

0.56

(3051387) C reactive protein [Mass/volume] in Capillary blood

632

1.29

1.41

4.3

3.6

27.30

27.60

mg/l

0.02

432

(3020393) Adenovirus Ag [Presence] in Stool

2.42

1.39

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

111

1356

0.81

1.37

1.1

1.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.61

1.36

1.3

1.0

—

(40757373) Influenza virus identified in Isolate

1.92

1.33

1.8

1.5

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.92

1.33

4.6

2.2

9.22

7.96

mmol/l

—

(3051101) Glucose [Moles/volume] in Cord blood

2.04

1.32

13.0

6.1

9.35

8.31

mmol/l

0.52

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.36

1.29

1.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.76

1.29

1.4

1.5

71.50

458.54

nmol/24h

0.67

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.78

1.28

5.0

7.4

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.40

1.24

1.3

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

278

1.41

1.24

1.3

33.38

30.76

u/l

0.13

227

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

204

1.47

1.22

2.6

1.9

97.22

118.93

ng/l

0.52

204

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.63

1.21

1.0

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.63

1.21

1.0

1.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.72

1.21

1.3

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

400

1.33

1.20

2.7

2.3

22.45

22.33

mg/l

0.01

150

(3024263) Appearance of Synovial fluid

164

1.53

1.20

1.8

1.6

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

101

1.69

1.19

1.4

1.3

152.67

119.80

nmol/l

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.83

1.19

17.9

1.7

—

(4212803) Bone marrow aspirate examination

2.31

1.18

1.0

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.88

1.18

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

393

1.33

1.17

1.2

1.3

0.18

0.19

nmol/l

0.35

314

(3023511) Choriogonadotropin [Units/volume] in Urine

166

1.51

1.14

1.4

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

156

0.51

1.13

1.4

1.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

151

1.53

1.11

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

143

1.54

1.11

1.3

1.7

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

104

1.64

1.09

1.1

1.0

86.75

89.85

0.15

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.38

1.09

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

112

1.61

1.08

1.2

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

149

0.54

1.03

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.77

1.00

1.2

1.1

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

2.00

1.00

1.1

1.6

1.17

1.41

umol/l

—

(1002224) Polysomnography panel

104

1230

0.84

0.98

1.1

—

(3014891) Appearance of Pleural fluid

1.84

0.98

2.6

1.6

—

(3012565) Volume of 24 hour Urine

156

1.48

0.98

2.3

2.6

2203.91

1912.89

0.52

138

(3047007) Chlamydophila sp Ab [Presence] in Serum

371

1.30

0.97

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

913

0.82

0.97

1.2

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.96

0.0

1.2

—

1.92

—

(3019150) Specific gravity of Urine by Refractometry

728

6883

1.07

0.96

5.6

4.3

1.02

kg/l

0.24

527

4628

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2742

27059

1.08

0.94

40.6

17.0

75.53

77.95

ml/min/173m2

5.98

2636

25254

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.65

0.94

1.0

—

(4024509) Urine culture

162

1423

1.15

0.92

2.2

2.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

339

3689

0.91

0.92

13.4

7.0

—

(3050794) Legionella sp Ab [Presence] in Serum

2.07

0.89

1.2

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

104

0.48

0.89

1.6

1.5

71.22

49.51

ug/l

—

104

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.91

0.88

1.0

2.2

14.79

19.44

umol/l

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

128

0.55

0.88

1.9

1.7

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2934

29608

0.91

0.88

54.6

22.8

89.32

79.73

umol/l

19.21

2916

29270

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

1.61

0.87

1.4

1.2

0.30

g/l

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.00

0.87

1.7

1.2

8.67

13.87

u/l

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.00

0.87

1.0

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

137

1.46

0.84

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.70

0.80

1.1

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.79

0.0

1.0

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.67

0.78

1.1

1.9

36.80

40.37

pmol/l

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

670

0.82

0.76

1.3

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

789

1.17

0.75

1.3

1.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

1.64

0.75

3.7

261.62

45.35

au/ml

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

329

3542

0.92

0.73

1.5

1.4

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.84

0.73

1.0

1.5

0.10

0.15

nmol/l

—

(1617658) Protocol used for examination of sentinel lymph nodes

218

0.69

0.71

1.0

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.75

0.71

1.0

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.58

0.71

1.6

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.92

0.70

1.4

1.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.92

0.70

1.0

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

160

1.38

0.70

9.8

6.7

149.89

45.14

u/ml

—

(3033099) Centromere Ab [Titer] in Serum

1.55

0.69

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

401

3760

1.08

0.69

5.4

5.2

32.18

32.77

0.52

331

2430

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.51

0.69

4.6

2.2

2.36

1.08

ug/l

0.67

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

135

1.41

0.69

1.5

1.7

2.17

9.65

nmol/l

1.16

107

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.53

0.69

1.2

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.67

0.68

1.0

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2716

26868

1.06

0.68

10.8

6.8

42.58

39.73

mmol/mol

29.21

2610

25053

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

272

0.73

0.66

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

406

0.79

0.66

4.4

5.3

333.56

349.70

umol/l

0.34

364

(3010144) Erythrocytes [#/volume] in Synovial fluid

306

1.24

0.62

1.2

1.4

25577.90

80600.48

e6/l

1.18

215

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.60

0.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

141

0.64

0.60

1.8

1.6

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.60

0.0

3.3

—

43.52

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.60

0.0

1.2

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.00

0.60

0.0

6.6

—

7.76

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

454

1.19

0.59

1.2

1.3

0.16

0.37

nmol/l

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.59

0.0

2.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.53

0.59

1.3

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

373

1.21

0.58

1.2

1.3

—

nmol/l

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

1.48

0.57

1.3

1.4

20.17

29.00

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

115

1.39

0.56

3.3

2.1

17.51

88.86

ug/l

0.54

105

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.43

0.56

1.0

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

212

1.28

0.55

1.3

1.28

1.98

u/ml

0.23

122

(3036071) Salmonella sp Ab [Titer] in Serum

1.47

0.54

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

1.50

0.54

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

205

0.73

0.54

1.5

1.4

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

906

0.88

0.52

1.5

2.0

57.19

41.98

nmol/l

3.68

871

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

188

2027

0.92

0.49

1.3

1.4

—

(3028717) Thiamine [Mass/volume] in Blood

1.49

0.47

1.1

1.2

57.43

68.53

ug/l

—

(3020874) Milk IgE Ab [Units/volume] in Serum

120

1.33

0.46

1.0

1.1

0.38

0.93

u/ml

—

(3005570) Glucose [Moles/volume] in Urine

292

1.20

0.45

2.1

2.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

263

0.80

0.43

1.0

0.86

0.29

u/ml

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

185

0.76

0.43

1.1

1.0

—

(44806420) Estimation of glomerular filtration rate

295

1.19

0.41

2.4

2.5

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.38

0.41

1.3

1.1

—

0.68

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.52

0.41

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.52

0.41

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.52

0.41

1.0

1.1

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

0.07

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

183

0.76

0.40

1.1

1.2

—

(40758292) HTLV I+II Ab panel - Serum

1.33

0.40

1.1

1.4

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.40

0.0

1.2

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

0.13

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.36

0.38

1.0

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.39

0.38

1.2

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.35

0.37

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

257

0.82

0.37

4.0

5.5

422.68

46.73

u/ml

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

300

0.83

0.36

1.1

—

23.20

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

353

0.85

0.36

1.0

1.1

0.44

1.73

u/ml

2.20

187

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.33

0.35

1.0

1.1

—

(3006270) Folate [Moles/volume] in Blood

226

1.20

0.35

1.4

1.2

254.67

365.32

nmol/l

1.90

200

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

434

1.13

0.33

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

286

0.84

0.33

1.0

1.1

0.94

4.52

u/ml

2.40

125

(3024666) Lithium [Moles/volume] in Serum or Plasma

118

1.27

0.33

15.5

12.8

0.61

mmol/l

0.03

112

(3016018) Differential panel - Cerebral spinal fluid

340

1.15

0.33

1.2

1.5

—

(3008898) HLA-B27 [Presence]

836

1.09

0.33

1.1

—

(44813793) Dust mix specific IgE antibody measurement

176

0.79

0.32

1.1

1.0

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2250

22699

0.97

0.32

54.7

22.3

330.34

332.05

g/l

12.42

2240

22581

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2709

27250

0.97

0.31

6.7

5.5

6.62

6.01

mmol/l

50.06

2554

24945

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

754

1.09

0.30

1.9

2.0

5.11

12.10

iu/l

0.40

289

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

154

1630

0.94

0.29

1.7

1.8

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

172

0.81

0.27

5.2

7.2

27.79

117.49

ug/l

—

105

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1.19

0.26

1.5

1.2

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.28

0.26

1.6

1.2

101.09

107.25

0.19

(3006462) Nitrate [Presence] in Urine

127

0.79

0.25

1.8

3.7

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

114

1.23

0.25

1.6

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

466

0.90

0.25

1.1

4.22

1.84

u/ml

0.40

263

(3023323) Follitropin [Units/volume] in Serum or Plasma

909

1.07

0.24

1.5

1.4

30.90

31.25

iu/l

0.03

772

(3008401) Mugwort IgE Ab [Units/volume] in Serum

381

0.89

0.24

1.0

0.89

1.12

u/ml

0.13

172

(3032773) Endomysium IgG Ab [Titer] in Serum

265

1.13

0.23

1.1

—

titre

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.32

0.23

2.2

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

209

1.15

0.22

2.8

1.6

596.17

305.81

mu/l

1.57

159

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.22

0.22

1.0

1.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.11

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

459.05

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.03

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.21

0.0

1.5

—

1.30

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.21

0.0

2.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.00

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.2

—

7.76

—

(3020650) Glucose [Presence] in Urine

103

0.78

0.21

1.4

2.0

0.00

0.06

estimate

—

103

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.20

0.0

1.2

—

2.71

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

1.97

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

115

0.78

0.20

1.0

1.2

18.33

9.85

mm/h

—

115

(4027681) Cerebrospinal fluid IgG ratio and IgG index

144

0.83

0.19

1.2

1.1

0.44

0.53

ratio

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

189

1824

1.04

0.18

1.3

46.25

62.51

au/ml

0.51

128

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

290

1.10

0.18

1.4

1.5

0.21

0.31

nmol/l

0.83

203

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

206

1995

1.03

0.17

2.6

2.4

27.94

20.89

au/ml

0.40

180

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.11

0.17

2.7

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

758

1.06

0.16

1.9

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.14

0.15

1.0

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

0.81

0.13

1.0

1.3

1.60

4.01

umol/l

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.18

0.12

1.0

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2924

29301

0.98

0.12

32.9

12.7

36.86

25.84

u/l

41.84

2902

28435

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

201

1.10

0.11

1.1

19.54

7.48

nmol/l

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2628

26352

0.99

0.11

5.7

4.5

1.36

1.30

mmol/l

3.86

2471

24114

(40768795) Lymph node Pathology biopsy report

319

1.07

0.10

1.3

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.11

0.09

1.0

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

135

0.89

0.09

1.0

1.3

6.38

6.13

mmol/l

0.35

129

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.09

0.09

1.6

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

379

1.06

0.09

1.2

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

380

1.05

0.09

1.2

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

117

1.11

0.08

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

784

0.97

0.08

1.6

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.07

0.07

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.05

0.07

1.0

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

132

0.91

0.06

1.1

40.20

420.64

ng/l

—

(4034850) Laboratory test

932

0.98

0.06

17.1

9.7

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

171

0.94

0.05

1.5

1.4

—

(4211845) Urine protein measurement

139

0.93

0.03

2.5

3.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.09

0.03

1.0

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

681

0.98

0.02

1.5

683.15

1178.65

e6/l

0.42

530

(3023410) Appearance of Cerebral spinal fluid

311

1.03

0.02

1.3

1.7

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

308

0.97

0.02

1.0

1.1

1.33

2.60

u/ml

0.75

155

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

332

1.02

0.01

1.2

1.3

10.10

7.44

mmol/l

2.57

286

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

148

1490

0.99

0.01

1.6

1.7

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

386

1.01

0.00

1.0

3.21

3.40

u/ml

0.03

199

(3025018) Bordetella pertussis Ab [Titer] in Serum

172

0.99

0.00

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

628

1.00

0.00

1.9

1.8

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

673

1.00

0.00

1.4

1.5

188.34

36.06

e6/l

0.40

492

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

32.62

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.53

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

0.03

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

0.0

1.0

—

7.80

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.00

0.0

2.2

—

36.40

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

67.33

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.0

1.0

—

3.42

—

(3006598) pH of Arterial cord blood

0.00

0.0

1.0

—

(4133840) Spirometry

0.91

-0.00

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.01

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_FIBROCHIRLIV and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_FIBROCHIRLIV	4.932 [4.37, 5.57]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.028

During the follow-up period (1.1.1998 — 31.12.2019), 2888 out of 6837 females with K11_FIBROCHIRLIV died.

Males

Parameter	HR [95% CI]	p-value
K11_FIBROCHIRLIV	7.217 [6.12, 8.51]	< 0.001
Birth year	0.985 [0.98, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 3915 out of 6725 males with K11_FIBROCHIRLIV died.

Mortality risk

Mortality risk for people of age

years, who have K11_FIBROCHIRLIV.

N-year risk	Females	Males
1	0.42%	1.153%
5	2.374%	6.99%
10	6.022%	16.152%
15	11.499%	29.88%
20	19.055%	47.457%

Relationships between endpoints

↥

Index endpoint: K11_FIBROCHIRLIV – Fibrosis and cirrhosis of liver

GWS hits: 4

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Fibrosis and cirrhosis of liver

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints